<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<meta content="" name="paf_template"/>
<meta content="pmc" name="ncbi_db"/><meta content="article" name="ncbi_pdid"/><meta content="" name="ncbi_acc"/><meta content="nihpa" name="ncbi_domain"/><meta content="record" name="ncbi_report"/><meta content="fulltext" name="ncbi_type"/><meta content="" name="ncbi_objectid"/><meta content="/articles/PMC3576702/" name="ncbi_pcid"/><meta content="pmc" name="ncbi_app"/>
<title>Cannabinoid Hyperemesis Syndrome</title>
<link href="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/css/jig.min.css" rel="stylesheet"/><script src="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/js/jig.min.js" type="text/javascript"></script>
<meta content="INDEX,NOFOLLOW,NOARCHIVE" name="robots"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/" rel="canonical"/><link href="http://purl.org/DC/elements/1.0/" rel="schema.DC"/><meta content="Current drug abuse reviews" name="citation_journal_title"/><meta content="Cannabinoid Hyperemesis Syndrome" name="citation_title"/><meta content="Jonathan A. Galli, Ronald Andari Sawaya, Frank K. Friedenberg" name="citation_authors"/><meta content="December 2011" name="citation_date"/><meta content="4" name="citation_issue"/><meta content="4" name="citation_volume"/><meta content="241" name="citation_firstpage"/><meta content="/pmc/articles/PMC3576702/?report=abstract" name="citation_abstract_html_url"/><meta content="22150623" name="citation_pmid"/><meta content="Cannabinoid Hyperemesis Syndrome" name="DC.Title"/><meta content="Text" name="DC.Type"/><meta content="NIH Public Access" name="DC.Publisher"/><meta content="Jonathan A. Galli" name="DC.Contributor"/><meta content="Ronald Andari Sawaya" name="DC.Contributor"/><meta content="Frank K. Friedenberg" name="DC.Contributor"/><meta content="2011 Dec" name="DC.Date"/><meta content="en" name="DC.Language"/><meta content="Cannabinoid Hyperemesis Syndrome" property="og:title"/><meta content="article" property="og:type"/><meta content="Coinciding with the increasing rates of cannabis abuse has been the recognition of a new clinical condition known as Cannabinoid Hyperemesis Syndrome. Cannabinoid Hyperemesis Syndrome is characterized by chronic cannabis use, cyclic episodes of nausea ..." property="og:description"/><meta content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/" property="og:url"/><meta content="PubMed Central (PMC)" property="og:site_name"/><meta content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" property="og:image"/><meta content="summary" name="twitter:card"/><meta content="@ncbi" name="twitter:site"/><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/css/3.14.1/pmc.min.css" rel="stylesheet" type="text/css"/><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" media="print" rel="stylesheet" type="text/css"/><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/common.min.js" type="text/javascript">//</script><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/NcbiTagServer.min.js" type="text/javascript">//</script><meta content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'" name="citationexporter"/><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js" type="text/javascript">//</script><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" rel="stylesheet" type="text/css"/><script src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js" type="text/javascript"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta content="" name="cited_in_systematic_reviews"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702//pmc/articles/PMC3576702/epub/" rel="alternate" type="application/epub+zip"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/pdf/nihms353647.pdf" rel="alternate" type="application/pdf"/>
<link href="//www.ncbi.nlm.nih.gov/favicon.ico" rel="shortcut icon"/><meta content="CE8CD570D27F33F100000000052102AE.m_8" name="ncbi_phid"/>
<meta content="origin-when-cross-origin" name="referrer"/><link href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" rel="stylesheet" type="text/css"/><link href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" rel="stylesheet" type="text/css"/><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
<body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
<div class="grid">
<div class="col twelve_col nomargin shadow">
<div class="sysmessages">
<noscript>
<p class="nojs">
<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="https://www.ncbi.nlm.nih.gov/guide/browsers/#enablejs" target="_blank" title="Learn how to enable JavaScript">more...</a>
</p>
</noscript>
</div>
<div class="wrap">
<div class="page">
<div class="top">
<div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a accesskey="1" class="ui-ncbimenu-link-first" href="https://www.ncbi.nlm.nih.gov/" id="ncbihome" role="menuitem" title="NCBI Home"><span class="offscreen_noflow">NCBI</span><img alt="NCBI Logo" class="ncbi_logo" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" title="NCBI"/></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="3" href="https://www.ncbi.nlm.nih.gov/#maincontent" tabindex="0" title="Skip to the content">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="4" href="https://www.ncbi.nlm.nih.gov/#navcontent" tabindex="0" title="Skip to the navigation">Skip to
                        navigation</a></li><li class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" id="resource-menu" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" role="menuitem" tabindex="-1">Resources</a></li><li class="topmenu ui-helper-reset ui-ncbimenu-item-first" id="all-howtos-menu" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" role="menuitem" tabindex="-1">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" tabindex="0" title="About My NCBI Accesskeys">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe scrolling="no" src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3576702%2F" style="border:none; height:2.5em; width:40em;"></iframe></div></div>
<div class="header">
<div class="res_logo">
<h1 class="img_logo"><a class="pmc_logo offscreen" href="https://www.ncbi.nlm.nih.gov/pmc/">PMC</a></h1>
<div class="NLMLogo">
<a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
<br/>
<a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
</div>
</div>
<div class="search"><form action="/pmc/" method="get"><div class="search_form"><label class="offscreen_noflow" for="database">Search database</label><select id="database"><optgroup label="Recent"><option class="last" data-ac_dict="pmc-search-autocomplete" selected="selected" value="pmc">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option data-ac_dict="pmc-search-autocomplete" value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label accesskey="/" class="offscreen_noflow" for="term">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input aria-autocomplete="list" aria-haspopup="true" autocomplete="off" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" id="term" name="term" role="textbox" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." type="text" value=""/><a class="reset" href="https://www.ncbi.nlm.nih.gov/#" style="visibility: hidden;"><img alt="Clear input" src="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/img/clear.png"/></a></div></div><button class="button_search nowrap" cmd="go" id="search" type="submit">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
<a href="https://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
</li><li>
<a href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
</li><li class="help">
<a href="https://www.ncbi.nlm.nih.gov/books/NBK3825/" target="_blank">Help</a>
</li></ul></div>
</div>
</div>
<div class="content">
<div class="container">
<div class="content eight_col col" id="maincontent">
<div class="navlink-box">
<ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal List</a></li><li class="article-entrez-filter"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/?term=hhs%20author%20manuscript[filter]">HHS Author Manuscripts</a></li><li class="accid">PMC3576702</li></ul>
</div>
<div class="pmc-page-banner whole_rhythm"><div><img alt="Logo of nihpa" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/logo-hhspa.png" usemap="#logo-imagemap"/><map id="logo-imagemap" name="logo-imagemap"><area alt="About Author manuscripts" coords="0,57,255,75" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" shape="rect" title="About Author manuscripts"/><area alt="Submit a manuscript" coords="256,57,500,75" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="Submit a manuscript"/><area alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" coords="0,0,499,74" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;"/></map></div> </div>
<div class="">
<div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a aria-expanded="false" aria-haspopup="true" href="https://www.ncbi.nlm.nih.gov/#" role="menuitem">Curr Drug Abuse Rev</a></span>. Author manuscript; available in PMC 2013 Feb 20.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22150623" ref="reftype=publisher&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access" target="pmc_ext"><span class="cit">Curr Drug Abuse Rev. 2011 Dec; 4(4): 241–249. </span></a></div> </div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3576702</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS353647</span></div><div class="fm-citation-pmid">PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/22150623">22150623</a></div></div></div></div><h1 class="content-title">Cannabinoid Hyperemesis Syndrome</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Galli%20JA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22150623">Jonathan A. Galli</a>, MD, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Sawaya%20RA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22150623">Ronald Andari Sawaya</a>, MD, and  <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Friedenberg%20FK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22150623">Frank K. Friedenberg</a>, MD</div><div class="contrib-group aff-tip" style="display:none"></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm139796981515184_ai">Author information</a> <a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm139796981515184_cpl">Copyright and License information</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139796981515184_ai" style="display:none"><div class="fm-affl" id="A1" lang="en">Department of Gastroenterology, Temple University School of Medicine, Philadelphia, PA</div><div id="FN1">Contact Info: Frank K. Friedenberg, MD, MS (Epi), Temple University Hospital, 3401 North Broad Street, Philadelphia, PA, 19140, Phone: 215-707-4391, Fax: 215-707-2684</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139796981515184_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="https://www.ncbi.nlm.nih.gov/pmc/about/copyright/">Copyright notice</a> </div></div></div><div class="links-box whole_rhythm" id="pmclinksbox"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22150623" ref="reftype=publisher&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access" target="pmc_ext">Curr Drug Abuse Rev</a></div><div>See other articles in PMC that <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div class="tsec sec" id="idm139796978612832" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="menuitem" title="Go to other sections in this page">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139796978612832title">Abstract</h2><div><p class="p p-first-last" id="P1">Coinciding with the increasing rates of cannabis abuse has been the recognition of a new clinical condition known as Cannabinoid Hyperemesis Syndrome. Cannabinoid Hyperemesis Syndrome is characterized by chronic cannabis use, cyclic episodes of nausea and vomiting, and frequent hot bathing. Cannabinoid Hyperemesis Syndrome occurs by an unknown mechanism. Despite the well-established anti-emetic properties of marijuana, there is increasing evidence of its paradoxical effects on the gastrointestinal tract and CNS. Tetrahydrocannabinol, cannabidiol, and cannabigerol are three cannabinoids found in the cannabis plant with opposing effects on the emesis response. The clinical course of Cannabinoid Hyperemesis Syndrome may be divided into three phases: prodromal, hyperemetic, and recovery phase. The hyperemetic phase usually ceases within 48 hours, and treatment involves supportive therapy with fluid resuscitation and anti-emetic medications. Patients often demonstrate the learned behavior of frequent hot bathing, which produces temporary cessation of nausea, vomiting, and abdominal pain. The broad differential diagnosis of nausea and vomiting often leads to delay in the diagnosis of Cannabinoid Hyperemesis Syndrome. Cyclic Vomiting Syndrome shares several similarities with CHS and the two conditions are often confused. Knowledge of the epidemiology, pathophysiology, and natural course of Cannabinoid Hyperemesis Syndrome is limited and requires further investigation.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Cannabinoid Hyperemesis Syndrome, Cannabis, Marijuana, Nausea, Vomiting</span></div></div><div class="tsec sec" id="S1"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">Epidemiology and Introduction</h2><p class="p p-first" id="P2">Cannabis is the most commonly used illicit drug in the United States with over 16.7 million users in 2009 [<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R1" rid="R1">1</a>]. The 18–25 year old age group has the highest prevalence of marijuana use [<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R1" rid="R1">1</a>]. Each year 2.6 million Americans become new users. The majority of these individuals are less than nineteen years of age [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R2" id="__tag_298888351" rid="R2">2</a>]. Similarly in Europe, cannabis use is prominent among young adults, with a prevalence that has increased from 5% in 1990 to 15% in 2005 [<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R3" rid="R3">3</a>]. While the overall prevalence of marijuana use has remained stable in the United States at 4%, the prevalence of cannabis use disorders (i.e. cannabis dependence, cannabis abuse) has continued to rise [<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R4" rid="R4">4</a>]. Risk factors for developing cannabis use disorders include male race, lower income, living in a Western culture, and being separated, divorced, or widowed [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R5" id="__tag_298888328" rid="R5">5</a>].</p><p class="p p-last" id="P3">Coinciding with the increasing rates of cannabis abuse has been the recognition of a new clinical condition known as Cannabinoid Hyperemesis Syndrome (CHS). The syndrome was first described in 2004 by Allen and colleagues and is characterized by chronic cannabis use, cyclic episodes of nausea and vomiting, and the learned behavior of hot bathing [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888385" rid="R6">6</a>]. This review will provide an overview of cannabinoid pharmacology that focuses on the properties that may contribute to CHS. We review a clinical description of CHS and a proposed clinical evaluation including differential diagnosis and treatment modalities. We conclude with a discussion regarding the shortcomings in our knowledge and suggestions for areas of future research</p></div><div class="tsec sec" id="S2"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">Pharmacology of Cannabinoids</h2><div class="sec sec-first" id="S3"><h3 id="S3title">The Cannabinoid Receptors</h3><p class="p p-first-last" id="P4">Two distinct cannabinoid receptors, CB<sub>1</sub> and CB<sub>2</sub>, have been identified in human and animal models. The CB<sub>1</sub> and CB<sub>2</sub> receptors function as G-protein coupled receptors that act by inhibiting adenylate cyclase [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R7" id="__tag_298888370" rid="R7">7</a>]. In the brain, CB<sub>1</sub> receptors are localized to the cerebral cortex, hypothalamus, anterior cingulate gyrus, hippocampus, cerebellum, and basal ganglia [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R8" id="__tag_298888318" rid="R8">8</a>]. In the gastrointestinal system, CB<sub>1</sub> receptors are found on both intrinsic and extrinsic neurons, with the enteric nervous system serving as the major site of action [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R9" id="__tag_298888363" rid="R9">9</a>]. Other organs where CB<sub>1</sub> receptors have been identified are the spleen, heart, liver, uterus, bladder, and vas deferens [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R10" id="__tag_298888378" rid="R10">10</a>]. In comparison, much less is known about the effects of the CB<sub>2</sub> receptor. CB<sub>2</sub> receptors are expressed primarily by immune cells [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R11" id="__tag_298888379" rid="R11">11</a>]. In the gastrointestinal system, CB<sub>2</sub> receptors are expressed by lamina propria plasma cells and activated macrophages, as well as by the myenteric and submucosal plexus ganglia in human ileum [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R9" id="__tag_298888443" rid="R9">9</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R12" id="__tag_298888382" rid="R12">12</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R13" id="__tag_298888418" rid="R13">13</a>]. CB<sub>2</sub> receptors are likely involved in the inhibition of inflammation, visceral pain, and intestinal motility in the inflamed gut [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R9" id="__tag_298888442" rid="R9">9</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R14" id="__tag_298888332" rid="R14">14</a>].</p></div><div class="sec" id="S4"><h3 id="S4title">The Endogenous Cannabinoids (Endocannabinoids)</h3><p class="p p-first-last" id="P5">Along with the discovery of the CB<sub>1</sub> and CB<sub>2</sub> receptors has been the identification of endogenous arachidonic acid derivatives that bind to these receptors (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure"><span>Figure 1</span></a>). These compounds are referred to as endogenous cannabinoids, or endocannabinoids. The best characterized endocannabinoids are anandamide and 2-arachidonylglycerol (2-AG) [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R9" id="__tag_298888374" rid="R9">9</a>]. The endocannabinoids are present in both the central nervous system [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R8" id="__tag_298888444" rid="R8">8</a>] and enteric nervous system [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R15" id="__tag_298888430" rid="R15">15</a>]. Anandamide and 2-AG are released locally on demand by neurons, are present in small quantities, and undergo rapid inactivation [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R8" id="__tag_298888375" rid="R8">8</a>]. Endocannabinoids are thought to act as either neuromodulators or neurotransmitters [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R11" id="__tag_298888337" rid="R11">11</a>]. Anandamide and 2-AG possess similar biochemical structures, but each has a distinct pathway for biosynthesis and degradation. Anandamide is synthesized from the precursor <em>N</em>-arachidonoyl phosphatidylethanolamine, while 2-AG is produced from an inositol-1,2-diacylglycerol precursor [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R8" id="__tag_298888369" rid="R8">8</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R16" id="__tag_298888354" rid="R16">16</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R17" id="__tag_298888423" rid="R17">17</a>]. The metabolism of anandamide is principally carried out via fatty acid amide hydrolase (FAAH), whereas the major enzyme metabolizing 2-AG is monoacylglycerol lipase (MAGL) [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R18" id="__tag_298888438" rid="R18">18</a>].</p><div class="fig iconblock whole_rhythm clearfix" co-legend-rid="lgnd_F1" id="F1"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure"></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139796975107888"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3576702_nihms353647f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms353647f1.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/bin/nihms353647f1.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm139796975107888" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F1/?report=objectonly" target="object">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure">Figure 1</a></div><div class="caption"><p id="__p1">Two well-characterized naturally occurring endocannabinoids are anandamide and 2-arachidonoylglycerol. Cannabinoids discovered in the cannabis plant with known effects on the regulation of emesis include tetrahydrocannabinol, cannabidiol, and cannabigerol.</p></div></div></div></div><div class="sec" id="S5"><h3 id="S5title">The Exogenous Cannabinoids</h3><p class="p p-first" id="P6">Δ<sup>9</sup>-tetrahydrocannabinol (THC) is the principle active compound in cannabis (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure"><span>Figure 1</span></a>). The metabolism of THC occurs mainly in the liver via oxidation and hydroxylation reactions. In humans this is carried out largely by the CYP2C isoenzyme subfamily of the cytochrome P450 complex [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R19" id="__tag_298888388" rid="R19">19</a>]. The true elimination plasma half-life of THC has been difficult to calculate, but several studies have estimated it to be in the range of 20–30 hours [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R20" id="__tag_298888361" rid="R20">20</a>]. THC is excreted mainly as acid metabolites, with 60–85% cleared through the feces and 20–35% in the urine [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R20" id="__tag_298888392" rid="R20">20</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R21" id="__tag_298888347" rid="R21">21</a>].</p><p id="P7">THC accumulates largely within body fat which serves as a long-term storage site for the drug [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R20" id="__tag_298888389" rid="R20">20</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R22" id="__tag_298888422" rid="R22">22</a>]. This characteristic partially explains its prolonged elimination half-life. A large reservoir of stored THC in fat tissue may produce a “reintoxication effect” secondary to increased lipolysis during times of increased stress or food deprivation [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R23" id="__tag_298888352" rid="R23">23</a>]. These characteristics of THC may have implications in Cannabinoid Hyperemesis Syndrome as these patients are chronic users of cannabis who likely have large lipid stores making them susceptible to increased cannabinoid levels in the plasma during times of stress.</p><p id="P8">Nearly 100 different metabolites have been identified for THC [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R24" id="__tag_298888327" rid="R24">24</a>]. The two major metabolites found in humans are 11-hydroxy-Δ<sup>9</sup>-tetrahydrocannabinol (11-OH-THC) and 11-nor-9-carboxy-THC- Δ<sup>9</sup>-tetrahydrocannabinol (THC-COOH) [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R20" id="__tag_298888391" rid="R20">20</a>]. 11-OH-COOH is a psychotropic metabolite that is equipotent to THC in terms of producing psychic effects and lowering intraocular pressure [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R25" id="__tag_298888384" rid="R25">25</a>]. THC-COOH, in contrast, is a non-psychotropic metabolite that possesses anti-inflammatory and analgesic properties [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R26" id="__tag_298888409" rid="R26">26</a>].</p><p id="P9">Cannabidiol (CBD) and cannabigerol (CBG) are two additional cannabinoids found in cannabis that appear to modulate the anti-emetic properties of THC. Cannabidiol, in contrast to THC, is non-psychotropic, has a low affinity for CB<sub>1</sub> and CB<sub>2</sub> receptors [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R27" id="__tag_326246057" rid="R27">27</a>], and acts as a partial agonist at the 5-HT<sub>1A</sub> receptor [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R28" id="__tag_298888417" rid="R28">28</a>]. CBD enhances the expression of CB<sub>1</sub> receptors in the hypothalamus and amplifies the hypothermic effects caused by THC [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R29" id="__tag_298888398" rid="R29">29</a>]. In animals the effect of CBD on toxin-induced vomiting displays a biphasic response with low doses producing an anti-emetic effect whereas higher doses enhance vomiting [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R30" id="__tag_298888359" rid="R30">30</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R31" id="__tag_298888426" rid="R31">31</a>].</p><p class="p p-last" id="P10">Cannabigerol (CBG) is a non-psychotropic cannabinoid that behaves as an antagonist at both the CB<sub>1</sub> and 5-HT<sub>1A</sub> receptors [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R32" id="__tag_298888407" rid="R32">32</a>]. This antagonism reverses the anti-emetic actions of low-dose CBD, which likely occurs at the 5-HT<sub>1A</sub> receptor [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R33" id="__tag_425411834" rid="R33">33</a>]. The pro-emetic properties of CBD (at higher doses) and CBG may play a role in the severe nausea and vomiting observed in patients with Cannabinoid Hyperemesis Syndrome (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F2" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"><span>Figure 2</span></a>).</p><div class="fig iconblock whole_rhythm clearfix" co-legend-rid="lgnd_F2" id="F2"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139796975104688"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3576702_nihms353647f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms353647f2.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/bin/nihms353647f2.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm139796975104688" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F2/?report=objectonly" target="object">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure">Figure 2</a></div><div class="caption"><p id="__p2">The cannabinoids demonstrate opposing effects on the emesis response. A disruption in this balance causing the pro-emetic properties to overcome the anti-emetic effects may explain the paradox observed in cannabinoid hyperemesis syndrome. Abbreviations: CBD: cannabidiol, CBG: cannabigerol, THC: tetrahydrocannabinol.</p></div></div></div></div><div class="sec" id="S6"><h3 id="S6title">The Effects of Cannabinoids in the Brain</h3><p class="p p-first" id="P11">Δ<sup>9</sup>-tetrahydrocannabinol (THC) has several well-established effects in the central nervous system, such as alteration of psychomotor behavior, impairment in short-term memory, stimulation of appetite, and analgesia [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R8" id="__tag_298888334" rid="R8">8</a>]. Rimonabant, a CB<sub>1</sub> antagonist, blocks the appetite stimulating qualities of the cannabinoids in the hypothalamus and has been marketed for the treatment of obesity and metabolic dysfunction [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R34" id="__tag_298888429" rid="R34">34</a>]. THC exhibits an anti-emetic effect in the central nervous system. In animal models, CB<sub>1</sub> receptor activation in the dorsal vagal complex of the brainstem mediates this effect [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R35" id="__tag_298888373" rid="R35">35</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R36" id="__tag_298888326" rid="R36">36</a>]. Dronabinol (synthetic THC) and nabilone (a CB<sub>1</sub> receptor agonist) are two commercially available cannabinoids for the treatment of chemotherapy-induced nausea and vomiting [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R37" id="__tag_298888336" rid="R37">37</a>].</p><p class="p p-last" id="P12">In the brain, the cannabinoid system helps regulate several aspects of the endocrine system. CB<sub>1</sub> receptor activation in the hypothalamus and pituitary gland results in modulation of all hypothalamic-pituitary axes [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R38" id="__tag_298888367" rid="R38">38</a>]. Receptor activation leads to inhibitory effects on the release of growth hormone, thyroid hormone, prolactin, and luteinizing hormone [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R38" id="__tag_298888316" rid="R38">38</a>]. In animal studies mice lacking CB<sub>1</sub> receptors demonstrate enhancement in circadian HPA axis activity peaks and impairment in glucocorticoid feedback [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R39" id="__tag_298888415" rid="R39">39</a>].</p></div><div class="sec sec-last" id="S7"><h3 id="S7title">The Effects of Cannabinoids in the Gastrointestinal System</h3><p class="p p-first-last" id="P13">The gastrointestinal actions of cannabinoids are mediated chiefly by CB<sub>1</sub> receptors (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F2" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"><span>Figure 2</span></a>). Activation of CB<sub>1</sub> receptors result in inhibition of gastric acid secretion, lower esophageal sphincter relaxation [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R40" id="__tag_298888425" rid="R40">40</a>], altered intestinal motility [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R41" id="__tag_298888390" rid="R41">41</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R42" id="__tag_326246059" rid="R42">42</a>], visceral pain, and inflammation [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R9" id="__tag_298888400" rid="R9">9</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R43" id="__tag_298888410" rid="R43">43</a>]. CB<sub>1</sub> receptor activation reduces gastric motility and results in delayed gastric emptying in rat models [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R44" id="__tag_298888402" rid="R44">44</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R45" id="__tag_298888362" rid="R45">45</a>]. In humans, THC given at doses used to prevent chemotherapy-induced nausea and vomiting causes a significant delay in gastric emptying [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R46" id="__tag_298888440" rid="R46">46</a>]. These findings in humans are further supported by a randomized, placebo-controlled trial with dronabinol that resulted in a significant delay in gastric emptying [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R47" id="__tag_298888436" rid="R47">47</a>]. In comparison to other adverse effects associated with cannabinoids, delayed gastric emptying appears to be particularly resistant to the development of tolerance [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R48" id="__tag_298888313" rid="R48">48</a>]. Additionally, intermittent administration of THC results in hypersensitization of the delayed gastric emptying effect [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R49" id="__tag_298888424" rid="R49">49</a>]. THC’s effect on gastric motility is a paradox, as a delay in gastric emptying would be expected to promote nausea and vomiting [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R50" id="__tag_326246055" rid="R50">50</a>]. However, nausea and vomiting traditionally do not occur with cannabis use, likely due to the anti-emetic properties of THC on the central nervous system.</p></div></div><div class="tsec sec" id="S8"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S8title">Clinical Presentation, work up and differential diagnosis of Cannabinoid Hyperemesis Syndrome</h2><p class="p p-first" id="P14">Two case series and numerous individual case reports have been published on Cannabinoid Hyperemesis Syndrome (CHS) (<a class="fig-table-link figpopup" co-legend-rid="" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/table/T1/" rid-figpopup="T1" rid-ob="ob-T1" target="table"><span>Table 1</span></a>). Patients present with recurrent episodes of nausea, vomiting, and dehydration with frequent visits to the emergency department. [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888349" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R51" id="__tag_298888394" rid="R51">51</a>–<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888325" rid="R62">62</a>]. Patients are typically young adults with a long history of cannabis use. In nearly all cases there is a delay of several years in the onset of symptoms preceded by chronic marijuana abuse [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888372" rid="R6">6</a>]. In one study the average duration of cannabis use prior to onset of recurrent vomiting was 16.3 ± 3.4 years [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888432" rid="R62">62</a>]. There are at least four reported cases where the time lag was equal to or less than three years [<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R54" rid="R54">54</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R59" id="__tag_326246053" rid="R59">59</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R60" id="__tag_298888434" rid="R60">60</a>]. Daily marijuana use is characteristic and often reported as exceeding three to five times per day.</p><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><div class="caption"><p id="__p3">Epidemiology, clinical presentation and follow up of patients with Hyperemesis Cannabis Syndrome - Longitudinal case series and individual case reports</p></div><div class="xtable" data-largeobj="" data-largeobj-link-rid="largeobj_idm139796982262864"><table class="rendered small default_table" frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1" valign="middle">Publication</th><th align="center" colspan="1" rowspan="1" valign="middle">Year</th><th align="center" colspan="1" rowspan="1" valign="middle">Country</th><th align="center" colspan="1" rowspan="1" valign="middle"><em>n</em></th><th align="center" colspan="1" rowspan="1" valign="middle">Gender</th><th align="center" colspan="1" rowspan="1" valign="middle">Age Started (y)</th><th align="center" colspan="1" rowspan="1" valign="middle">Frequency (joints/day)</th><th align="center" colspan="1" rowspan="1" valign="middle">Age of presentation (y)</th><th align="center" colspan="1" rowspan="1" valign="middle">Illness duration (y)</th><th align="center" colspan="1" rowspan="1" valign="middle">Prodromal Illness</th><th align="center" colspan="1" rowspan="1" valign="middle">Abdominal Pain</th><th align="center" colspan="1" rowspan="1" valign="middle">Hot Bathing (No./day)</th><th align="center" colspan="1" rowspan="1" valign="middle">Weight Loss (Kg)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Allen J</strong>. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse</td><td align="center" colspan="1" rowspan="1" valign="middle">2004</td><td align="center" colspan="1" rowspan="1" valign="middle">Australia</td><td align="center" colspan="1" rowspan="1" valign="middle">9</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">15.7 (12–19)</td><td align="center" colspan="1" rowspan="1" valign="middle">88% (≥5–10)</td><td align="center" colspan="1" rowspan="1" valign="middle">24.6 (14–44)</td><td align="center" colspan="1" rowspan="1" valign="middle">4.7 (0.5–12)</td><td align="center" colspan="1" rowspan="1" valign="middle">33%</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">77%</td><td align="center" colspan="1" rowspan="1" valign="middle">66% (≥10)</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Soriano M</strong>. The Cannabis Hyperemesis Syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: A report of eight cases in the United States</td><td align="center" colspan="1" rowspan="1" valign="middle">2010</td><td align="center" colspan="1" rowspan="1" valign="middle">US</td><td align="center" colspan="1" rowspan="1" valign="middle">8</td><td align="center" colspan="1" rowspan="1" valign="middle">M (62.5%)</td><td align="center" colspan="1" rowspan="1" valign="middle">13.3 (9–20)</td><td align="center" colspan="1" rowspan="1" valign="middle">75% (≥3–10)</td><td align="center" colspan="1" rowspan="1" valign="middle">34.1 (21–35)</td><td align="center" colspan="1" rowspan="1" valign="middle">2.6 (1–8)</td><td align="center" colspan="1" rowspan="1" valign="middle">100%</td><td align="center" colspan="1" rowspan="1" valign="middle">100%</td><td align="center" colspan="1" rowspan="1" valign="middle">100% (≥3–8)</td><td align="center" colspan="1" rowspan="1" valign="middle">75% (≥10)</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Patterson D</strong>. Cannabinoid Hyperemesis and compulsive bathing: A case series and paradoxical pathophysiological explanation</td><td align="center" colspan="1" rowspan="1" valign="middle">2010</td><td align="center" colspan="1" rowspan="1" valign="middle">US</td><td align="center" colspan="1" rowspan="1" valign="middle">4</td><td align="center" colspan="1" rowspan="1" valign="middle">M (100%)</td><td align="center" colspan="1" rowspan="1" valign="middle">18.7 (15–27)</td><td align="center" colspan="1" rowspan="1" valign="middle">75% (≥4)<sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">25.5 (18–39)</td><td align="center" colspan="1" rowspan="1" valign="middle">4.75 (8m–9)</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">50%<sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">50%</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Donnino M</strong>. Cannabinoid Hyperemesis: A case series</td><td align="center" colspan="1" rowspan="1" valign="middle">2009</td><td align="center" colspan="1" rowspan="1" valign="middle">US</td><td align="center" colspan="1" rowspan="1" valign="middle">3</td><td align="center" colspan="1" rowspan="1" valign="middle">M (100%)</td><td align="center" colspan="1" rowspan="1" valign="middle">33.5 (23–51)<sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">66% (≥2–4)</td><td align="center" colspan="1" rowspan="1" valign="middle">29.6 (20–49)</td><td align="center" colspan="1" rowspan="1" valign="middle">2.3 (2–3)</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Miller J</strong>. Pediatric Cannabinoid Hyperemesis</td><td align="center" colspan="1" rowspan="1" valign="middle">2010</td><td align="center" colspan="1" rowspan="1" valign="middle">US</td><td align="center" colspan="1" rowspan="1" valign="middle">2</td><td align="center" colspan="1" rowspan="1" valign="middle">M (50%)</td><td align="center" colspan="1" rowspan="1" valign="middle">17.5 (17–18)</td><td align="center" colspan="1" rowspan="1" valign="middle">Daily</td><td align="center" colspan="1" rowspan="1" valign="middle">16<sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">2<sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes<sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Chang Y</strong>. Cannabinoid Hyperemesis relieved by compulsive bathing</td><td align="center" colspan="1" rowspan="1" valign="middle">2009</td><td align="center" colspan="1" rowspan="1" valign="middle">US</td><td align="center" colspan="1" rowspan="1" valign="middle">2</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">16 (14–18)</td><td align="center" colspan="1" rowspan="1" valign="middle">Daily</td><td align="center" colspan="1" rowspan="1" valign="middle">17 (14–20)</td><td align="center" colspan="1" rowspan="1" valign="middle">8.5 (7–9)</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Seraina M</strong>. Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy</td><td align="center" colspan="1" rowspan="1" valign="middle">2010</td><td align="center" colspan="1" rowspan="1" valign="middle">Switzerland</td><td align="center" colspan="1" rowspan="1" valign="middle">1</td><td align="center" colspan="1" rowspan="1" valign="middle">F</td><td align="center" colspan="1" rowspan="1" valign="middle">23</td><td align="center" colspan="1" rowspan="1" valign="middle">Daily</td><td align="center" colspan="1" rowspan="1" valign="middle">20</td><td align="center" colspan="1" rowspan="1" valign="middle">3</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Sannarangappa V</strong>. Cannabinoid hyperemesis</td><td align="center" colspan="1" rowspan="1" valign="middle">2009</td><td align="center" colspan="1" rowspan="1" valign="middle">Australia</td><td align="center" colspan="1" rowspan="1" valign="middle">1</td><td align="center" colspan="1" rowspan="1" valign="middle">M</td><td align="center" colspan="1" rowspan="1" valign="middle">19</td><td align="center" colspan="1" rowspan="1" valign="middle">8</td><td align="center" colspan="1" rowspan="1" valign="middle">24</td><td align="center" colspan="1" rowspan="1" valign="middle">10</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Sontineni S</strong>. Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse</td><td align="center" colspan="1" rowspan="1" valign="middle">2009</td><td align="center" colspan="1" rowspan="1" valign="middle">US</td><td align="center" colspan="1" rowspan="1" valign="middle">1</td><td align="center" colspan="1" rowspan="1" valign="middle">M</td><td align="center" colspan="1" rowspan="1" valign="middle">16</td><td align="center" colspan="1" rowspan="1" valign="middle">Daily</td><td align="center" colspan="1" rowspan="1" valign="middle">22</td><td align="center" colspan="1" rowspan="1" valign="middle">2 months</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Watts M</strong>. Cannabinoid hyperemesis presenting to a New Zealand hospital</td><td align="center" colspan="1" rowspan="1" valign="middle">2009</td><td align="center" colspan="1" rowspan="1" valign="middle">New Zeeland</td><td align="center" colspan="1" rowspan="1" valign="middle">1</td><td align="center" colspan="1" rowspan="1" valign="middle">M</td><td align="center" colspan="1" rowspan="1" valign="middle">18</td><td align="center" colspan="1" rowspan="1" valign="middle">Daily</td><td align="center" colspan="1" rowspan="1" valign="middle">29</td><td align="center" colspan="1" rowspan="1" valign="middle">3</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Budhraja V</strong>. Cannabinoid Hyperemesis Syndrome: Cyclic vomiting, chronic cannabis use, and compulsive bathing</td><td align="center" colspan="1" rowspan="1" valign="middle">2008</td><td align="center" colspan="1" rowspan="1" valign="middle">US</td><td align="center" colspan="1" rowspan="1" valign="middle">1</td><td align="center" colspan="1" rowspan="1" valign="middle">M</td><td align="center" colspan="1" rowspan="1" valign="middle">16</td><td align="center" colspan="1" rowspan="1" valign="middle">Daily</td><td align="center" colspan="1" rowspan="1" valign="middle">18</td><td align="center" colspan="1" rowspan="1" valign="middle">8 months</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Wallace D</strong>. Cannabinoid hyperemesis: marijuana puts patients in hot water</td><td align="center" colspan="1" rowspan="1" valign="middle">2007</td><td align="center" colspan="1" rowspan="1" valign="middle">Australia</td><td align="center" colspan="1" rowspan="1" valign="middle">1</td><td align="center" colspan="1" rowspan="1" valign="middle">M</td><td align="center" colspan="1" rowspan="1" valign="middle">14</td><td align="center" colspan="1" rowspan="1" valign="middle">≥1g/1–2 day</td><td align="center" colspan="1" rowspan="1" valign="middle">25</td><td align="center" colspan="1" rowspan="1" valign="middle">5</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Singh E</strong>. Cannabinoid Hyperemesis</td><td align="center" colspan="1" rowspan="1" valign="middle">2006</td><td align="center" colspan="1" rowspan="1" valign="middle">US</td><td align="center" colspan="1" rowspan="1" valign="middle">1</td><td align="center" colspan="1" rowspan="1" valign="middle">M</td><td align="center" colspan="1" rowspan="1" valign="middle">Childhood</td><td align="center" colspan="1" rowspan="1" valign="middle">4</td><td align="center" colspan="1" rowspan="1" valign="middle">43</td><td align="center" colspan="1" rowspan="1" valign="middle">3</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">≥9</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle"><strong>Roche E</strong>. Cannabinoid hyperemesis: not just a problem in Adelaide Hills</td><td align="center" colspan="1" rowspan="1" valign="middle">2005</td><td align="center" colspan="1" rowspan="1" valign="middle">UK</td><td align="center" colspan="1" rowspan="1" valign="middle">1</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">2</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139796982262864" style=""><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/table/T1/?report=objectonly" target="object">Open in a separate window</a></div><div class="xtable" data-largeobj="" data-largeobj-link-rid="largeobj_idm139796978520176"><table class="rendered small default_table" frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1" valign="middle">Publication</th><th align="center" colspan="1" rowspan="1" valign="middle">Laboratory</th><th align="center" colspan="1" rowspan="1" valign="middle">UDS (+)</th><th align="center" colspan="1" rowspan="1" valign="middle">EGD</th><th align="center" colspan="1" rowspan="1" valign="middle">GES</th><th align="center" colspan="1" rowspan="1" valign="middle">Psychiatric Dx</th><th align="center" colspan="1" rowspan="1" valign="middle">Cannabis Cessation (length)</th><th align="center" colspan="1" rowspan="1" valign="middle">Resolution of Symptoms</th><th align="center" colspan="1" rowspan="1" valign="middle">Weight Gain (Kg)</th><th align="center" colspan="1" rowspan="1" valign="middle">Cannabis Resumption</th><th align="center" colspan="1" rowspan="1" valign="middle">Recurrence of symptoms</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1" valign="middle">Allen J. <em>et al</em> 2004</td><td align="center" colspan="1" rowspan="1" valign="middle">44% (Leukocytosis)</td><td align="center" colspan="1" rowspan="1" valign="middle">100%</td><td align="center" colspan="1" rowspan="1" valign="middle">44% (gastritis)</td><td align="center" colspan="1" rowspan="1" valign="middle">1 (delayed); 2 (normal); rest (N/A)</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">77% (9–48 months)</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">66% (≥5)</td><td align="center" colspan="1" rowspan="1" valign="middle">55%</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Soriano M. <em>et al</em> 2010</td><td align="center" colspan="1" rowspan="1" valign="middle">12.5% (Leukocytosis)</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">75% (esophagitis)</td><td align="center" colspan="1" rowspan="1" valign="middle">1 (normal)</td><td align="center" colspan="1" rowspan="1" valign="middle">25% (depression, panic attacks)</td><td align="center" colspan="1" rowspan="1" valign="middle">62.5% (N/A)</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes (80%)</td><td align="center" colspan="1" rowspan="1" valign="middle">80% (≥5)</td><td align="center" colspan="1" rowspan="1" valign="middle">25%</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Patterson D. <em>et al</em> 2010</td><td align="center" colspan="1" rowspan="1" valign="middle">25% (Hypokalemia)</td><td align="center" colspan="1" rowspan="1" valign="middle">50% <sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">75% (gastritis)</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">100% (1m-1)<sup>°</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">100%</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Donnino M. <em>et al</em> 2009</td><td align="center" colspan="1" rowspan="1" valign="middle">Hypokalemia</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">1 (Normal)<sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">66% (2–14 months)</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Miller J. <em>et al</em> 2010</td><td align="center" colspan="1" rowspan="1" valign="middle">Hypokalemia</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Esophageal rings, gastritis</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">ADHD, depression</td><td align="center" colspan="1" rowspan="1" valign="middle">1 month<sup>*</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Chang Y, Windish D. 2009</td><td align="center" colspan="1" rowspan="1" valign="middle">Leukocytosis</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">Delayed</td><td align="center" colspan="1" rowspan="1" valign="middle">Bipolar Disorder</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Seraina M. <em>et al 2010</em></td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Psychogenic vomiting (?)</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes<sup>°</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Sannarangappa V, Tan C. 2009</td><td align="center" colspan="1" rowspan="1" valign="middle">Leukocytosis, AKI</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">2<sup>◆</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Sontineni S. <em>et al</em> 2009</td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Esophagitis, Hiatal hernia</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes<sup>°</sup></td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Watts M. 2009</td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Budhraja V. <em>et al</em> 2008</td><td align="center" colspan="1" rowspan="1" valign="middle">Hypokalemia</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Gastritis</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">5 months</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Wallace D. <em>et al</em> 2007</td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Anxiety, depression, OCD</td><td align="center" colspan="1" rowspan="1" valign="middle">2</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Singh E, Coyle W. 2006</td><td align="center" colspan="1" rowspan="1" valign="middle">Normal</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">4 months</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Roche E, Foster P. 2005</td><td align="center" colspan="1" rowspan="1" valign="middle">Neutrophilia</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">Esophagitis</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">3</td><td align="center" colspan="1" rowspan="1" valign="middle">Yes</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td><td align="center" colspan="1" rowspan="1" valign="middle">-</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139796978520176" style=""><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/table/T1/?report=objectonly" target="object">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>*</sup>Rest not reported or not available</div><div id="TFN2"><sup>°</sup>Period of time not specified</div><div id="TFN3"><p class="p p-first-last" id="__p6"><em>n</em> Cases reported, OCD Obsessive Compulsive Disorder, Creat Creatinine, ADHD Attention deficit hyperactivity disorder</p></div><div id="TFN4"><sup>*</sup>Rest not reported or not available</div><div id="TFN5"><sup>°</sup>Period of time not specified</div><div id="TFN6"><p class="p p-first-last" id="__p9"><em>n</em> Cases reported, OCD Obsessive Compulsive Disorder, AKI Acute Kidney Injury, ADHD Attention deficit hyperactivity disorder</p></div></div></div><p id="P15">CHS is a recurrent disorder interspersed with symptom-free intervals. It has been proposed to divide CHS into three phases: pre-emetic or prodromal, hyperemetic, and recovery phase [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888356" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888393" rid="R62">62</a>]. The prodromal phase can last for months or years with patients developing early morning nausea, a fear of vomiting, and abdominal discomfort [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888421" rid="R62">62</a>]. In this stage patients maintain normal eating patterns, and may increase or continue the use of cannabis because of the believed beneficial effects on relieving nausea [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R52" id="__tag_298888412" rid="R52">52</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R56" id="__tag_298888413" rid="R56">56</a>]. The hyperemetic phase is characterized by paroxysms of intense and persistent nausea and vomiting, commonly described as overwhelming and incapacitating. Patients vomit profusely, often without warning and can vomit and retch up to five times per hour [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888324" rid="R62">62</a>]. Most patients also present with diffuse but relatively mild abdominal pain. In one series approximately 70% of patients reported marked weight loss of at least 5 kg during their illness [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888342" rid="R6">6</a>]. In the emergency department patients are found to be dehydrated but hemodynamically stable. They undergo an extensive diagnostic work up, including laboratory and imaging studies which, in the majority of cases, are unrevealing. During the hyperemetic phase patients stereotypically take numerous hot showers throughout the day. This idiosyncratic behavior appears to be learned and is repeatedly used as the only alleviating measure to control symptoms and rapidly becomes a compulsive behavior. The recovery phase can last for days, weeks, or months and is associated with relative wellness and normal eating patterns. Weight is regained and bathing returns to regular frequency.</p><p id="P16">Patients with CHS usually remain misdiagnosed for a considerable time period. In one case series the average number of emergency room visits (7.1 ± 4.3) prior to diagnosis and the delay in diagnosis (for up to 9 years) was substantial [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888348" rid="R62">62</a>]. Not surprisingly, the early identification of patients with CHS leads to a reduction in morbidity and costs [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888386" rid="R6">6</a>]. The differential diagnosis of nausea and vomiting is extensive and includes a broad range of pathologic conditions affecting the gastrointestinal tract, the peritoneal cavity, CNS, as well as endocrine and metabolic functions [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R63" id="__tag_298888312" rid="R63">63</a>]. The initial approach to evaluate a patient with cyclical vomiting should start by excluding these vast disorders. In this context a comprehensive history along with initial screening tests should be performed to exclude acute conditions and emergencies (e.g pancreatobiliary disease, intestinal obstruction, pregnancy, etc). This includes laboratory tests (complete blood count and differential, glucose, basic metabolic panel, pancreatic and hepatic enzymes, pregnancy test), urinalysis, urinary drug screen, and plain flat radiographic series [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R63" id="__tag_298888428" rid="R63">63</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R64" id="__tag_298888353" rid="R64">64</a>].</p><p id="P17">Further imaging and invasive testing must be tailored to the individual presentation. For example, associated symptoms like hematemesis should prompt an upper endoscopy, neurological findings would support brain imaging, and pronounced abdominal tenderness justifies an abdominal CT or abdominal radiographic series [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R64" id="__tag_298888383" rid="R64">64</a>]. In the absence of positive findings on these diagnostic workups the possibility of an underlying motility disorder such as gastroparesis, intestinal pseudo-obstruction or small bowel dysmotility should be considered [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R63" id="__tag_298888403" rid="R63">63</a>].</p><p class="p p-last" id="P18">In clinical practice CHS is most often confused with cyclic vomiting syndrome (CVS). In fact patients with CHS are often mislabeled as having CVS and vice versa. Confusion exists in the medical literature secondary to a failure to recognize chronic marijuana use as a source of vomiting. For example, in two recently published series of adult patients with CVS, approximately one third of patients reported daily marijuana use [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R65" id="__tag_326246054" rid="R65">65</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R66" id="__tag_298888433" rid="R66">66</a>]. Based on the categorization of functional disorders developed by Rome III, chronic marijuana use (CHS) is recognized as a mechanism for nausea and vomiting distinct from CVS [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R67" id="__tag_298888322" rid="R67">67</a>]. Although both conditions share an astonishing similarity, there are several significant differences. For example, CVS patients usually have important psychological comorbidities including depression and anxiety [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R64" id="__tag_298888321" rid="R64">64</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R65" id="__tag_326246058" rid="R65">65</a>]. In addition, CVS patients have a high prevalence of migraine headaches or a family history of migraines. Furthermore, gastric emptying rates in patients with CVS are often accelerated rather than delayed [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R46" id="__tag_298888335" rid="R46">46</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R65" id="__tag_326246051" rid="R65">65</a>]. <a class="fig-table-link figpopup" co-legend-rid="" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/table/T2/" rid-figpopup="T2" rid-ob="ob-T2" target="table"><span>Table 2</span></a> summarizes some of the epidemiological and clinical characteristics that may help distinguish CVS and CHS.</p><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><div class="caption"><p id="__p10">Comparison of cyclic vomiting syndrome in adults and cannabis hyperemesis syndrome</p></div><div class="xtable" data-largeobj="" data-largeobj-link-rid="largeobj_idm139796979241152"><table class="rendered small default_table" frame="hsides" rules="groups"><thead><tr><th align="center" colspan="1" rowspan="1" valign="middle"></th><th align="center" colspan="1" rowspan="1" valign="middle">Cyclical Vomiting</th><th align="center" colspan="1" rowspan="1" valign="middle">Cannabis Hyperemesis Syndrome</th></tr></thead><tbody><tr><td align="center" colspan="1" rowspan="1" valign="middle">Age at diagnosis (y)</td><td align="center" colspan="1" rowspan="1" valign="middle">34.8</td><td align="center" colspan="1" rowspan="1" valign="middle">29.3</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Delay in diagnosis (y)</td><td align="center" colspan="1" rowspan="1" valign="middle">7.9</td><td align="center" colspan="1" rowspan="1" valign="middle">3.1</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Duration of episodes (days)</td><td align="center" colspan="1" rowspan="1" valign="middle">3.8</td><td align="center" colspan="1" rowspan="1" valign="middle">N/A</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Cannabis use</td><td align="center" colspan="1" rowspan="1" valign="middle">Occasionally</td><td align="center" colspan="1" rowspan="1" valign="middle">Universal</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Triggering factors (e.g. infections, psychological stress, etc)</td><td align="center" colspan="1" rowspan="1" valign="middle">Frequent</td><td align="center" colspan="1" rowspan="1" valign="middle">Absent</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Prodrome</td><td align="center" colspan="1" rowspan="1" valign="middle">Common</td><td align="center" colspan="1" rowspan="1" valign="middle">Common</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle"><strong>Clinical findings</strong></td><td align="center" colspan="1" rowspan="1" valign="middle"></td><td align="center" colspan="1" rowspan="1" valign="middle"></td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Vomiting</td><td align="center" colspan="1" rowspan="1" valign="middle">Universal</td><td align="center" colspan="1" rowspan="1" valign="middle">Universal</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Abdominal Pain</td><td align="center" colspan="1" rowspan="1" valign="middle">Common (58–71%) – Moderate to severe</td><td align="center" colspan="1" rowspan="1" valign="middle">Common – Mild to moderate</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Compulsive Bathing</td><td align="center" colspan="1" rowspan="1" valign="middle">Absent</td><td align="center" colspan="1" rowspan="1" valign="middle">Universal</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">GES</td><td align="center" colspan="1" rowspan="1" valign="middle">Accelerated</td><td align="center" colspan="1" rowspan="1" valign="middle">Delayed</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Comorbidities Psychiatric</td><td align="center" colspan="1" rowspan="1" valign="middle">Common</td><td align="center" colspan="1" rowspan="1" valign="middle">Not common</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Migraine headache</td><td align="center" colspan="1" rowspan="1" valign="middle">Common (24–70%)</td><td align="center" colspan="1" rowspan="1" valign="middle">Not common</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Treatment</td><td align="center" colspan="1" rowspan="1" valign="middle">Abortive measures (antimigraine agents), supportive care, psychological support</td><td align="center" colspan="1" rowspan="1" valign="middle">Cannabis cessation, supportive care</td></tr><tr><td align="center" colspan="1" rowspan="1" valign="middle">Prophylaxis</td><td align="center" colspan="1" rowspan="1" valign="middle">Avoid triggers, TCA</td><td align="center" colspan="1" rowspan="1" valign="middle">Cannabis cessation</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139796979241152" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/table/T2/?report=objectonly" target="object">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN7"><p class="p p-first-last" id="__p11">Data from Abell TL et al, Allen J et al and Soriano M et al.</p></div><div id="TFN8"><p class="p p-first-last" id="__p12">N/A Not available, GES Gastric emptying study, TCA Tricyclic antidepressants</p></div></div></div></div><div class="tsec sec" id="S9"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S9title">Treatment</h2><p class="p p-first" id="P19">The treatment of Cannabinoid Hyperemesis Syndrome can be divided into therapy for the hyperemetic phase and the prevention of relapse. Patients may require hospitalization during the hyperemetic phase secondary to abdominal pain, volume depletion, and severe nausea and vomiting. Supportive therapy, albeit not very effective, serves as the mainstay of treatment during this phase of the syndrome [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888340" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R53" id="__tag_326246060" rid="R53">53</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888331" rid="R62">62</a>]. For volume depletion aggressive resuscitation with intravenous fluids is needed [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888441" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R59" id="__tag_326246056" rid="R59">59</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R61" id="__tag_298888333" rid="R61">61</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888399" rid="R62">62</a>]. Anti-emetic therapy can be tried with 5-HT<sub>3</sub> receptor antagonists, D<sub>2</sub> receptor antagonists, H<sub>1</sub> receptor antagonists, and neurokinin-1 receptor antagonists. However, all have been shown to provide minimal or no improvement in most patients with CHS [<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R54" rid="R54">54</a>–<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R58" id="__tag_298888366" rid="R58">58</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888397" rid="R62">62</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R68" id="__tag_425411831" rid="R68">68</a>]. Narcotics have also been attempted in a few cases to relieve associated abdominal pain [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R55" id="__tag_298888411" rid="R55">55</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R57" id="__tag_298888416" rid="R57">57</a>]. Opioids should be used with caution, however, as they have the potential to cause emesis. [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R69" id="__tag_298888408" rid="R69">69</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R70" id="__tag_298888358" rid="R70">70</a>]. Esophagogastroduodenoscopy findings from several patients with CHS have revealed varying grades of esophagitis and gastritis [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888435" rid="R6">6</a>,<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R54" rid="R54">54</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R57" id="__tag_298888419" rid="R57">57</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R60" id="__tag_298888414" rid="R60">60</a>–<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888427" rid="R62">62</a>]. As a result, acid suppression therapy with medications such as proton pump inhibitors should be given routinely.</p><p id="P20">The most effective treatment during the hyperemetic phase of CHS is the use of hot showers by patients. The effects of this learned behavior are temperature-dependent [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888437" rid="R6">6</a>], fast acting [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888376" rid="R6">6</a>], but short-lived [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888431" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R56" id="__tag_298888364" rid="R56">56</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888439" rid="R62">62</a>]. Hot showers improve symptoms of nausea and vomiting [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888355" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R52" id="__tag_298888447" rid="R52">52</a>–<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R56" id="__tag_298888344" rid="R56">56</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R60" id="__tag_298888343" rid="R60">60</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888323" rid="R62">62</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R68" id="__tag_425411832" rid="R68">68</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R71" id="__tag_298888446" rid="R71">71</a>], abdominal pain [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888338" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R56" id="__tag_298888377" rid="R56">56</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R71" id="__tag_298888345" rid="R71">71</a>], and decreased appetite [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R68" id="__tag_425411833" rid="R68">68</a>] during the hyperemetic phase. The precise mechanism by which hot bathing produces a rapid reduction in the symptoms of CHS is unknown. It has been proposed that hot bathing may act by correcting the cannabis-induced disequilibrium of the thermoregulatory system of the hypothalamus [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888319" rid="R6">6</a>]. Darmani has suggested that cannabis increases the core body temperature while concomitantly decreasing skin temperature thus increasing blood flow to the skin and dissipating excess core body heat [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R72" id="__tag_761173405" rid="R72">72</a>].</p><p class="p p-last" id="P21">The hyperemetic phase of CHS typically lasts for only 24–48 hours [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888420" rid="R6">6</a>], but the risk for relapse is high if the patient returns to cannabis use. Case reports have demonstrated a remission in CHS symptoms upon cessation of cannabis use for extended periods [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888381" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R51" id="__tag_298888406" rid="R51">51</a>–<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R54" rid="R54">54</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R57" id="__tag_298888317" rid="R57">57</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R59" id="__tag_326246049" rid="R59">59</a>–<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888315" rid="R62">62</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R68" id="__tag_425411835" rid="R68">68</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R71" id="__tag_298888445" rid="R71">71</a>]. Unfortunately, many of these patients relapse upon resuming cannabis [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888360" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R59" id="__tag_326246052" rid="R59">59</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R61" id="__tag_298888380" rid="R61">61</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888371" rid="R62">62</a>]. It has been suggested that many of these patients increase or continue their cannabis use because of their perception that it will have beneficial effects on nausea [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R52" id="__tag_298888341" rid="R52">52</a>]. Patient education should therefore be provided with emphasis on the paradoxical nature of the symptoms of CHS. Furthermore, some authors have reported referring patients to drug rehabilitation programs in an attempt to raise the likelihood of long-term cannabis cessation [<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R54" rid="R54">54</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R71" id="__tag_298888365" rid="R71">71</a>]. Studies have demonstrated the efficacy of outpatient treatment options such as cognitive behavioral therapy and motivational enhancement therapy for marijuana dependence [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R73" id="__tag_298888346" rid="R73">73</a>].</p></div><div class="tsec sec" id="S10"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S10title">Shortcomings in our knowledge of CHS and areas for future research</h2><p class="p p-first" id="P22">There are several shortcomings in our understanding of CHS. There exists no epidemiological data regarding the incidence and prevalence of CHS among chronic marijuana users. The syndrome is likely underreported given its recent recognition [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R74" id="__tag_326246050" rid="R74">74</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R75" id="__tag_298888329" rid="R75">75</a>]. With the large prevalence of marijuana use in the world, why does it appear that so few patients develop CHS? Certain individuals may have a genetic polymorphisms in the cytochrome P450 enzymes responsible for the metabolism of the cannabinoids [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888396" rid="R62">62</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R72" id="__tag_761173404" rid="R72">72</a>]. This could result in excessive levels of pro-emetic cannabinoids or emetogenic metabolites. Such genetic variations have yet to be studied in patients diagnosed with CHS and represent an area for future research.</p><p id="P23">The mechanism by which cannabis induces hyperemesis is presently unknown. A recent review has explored numerous potential explanations regarding various pharmacokinetic and pharmacodynamic factors of the cannabinoids [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R72" id="__tag_761173406" rid="R72">72</a>]. The cannabis plant contains over four hundred different chemicals, with sixty possessing cannabinoid structures [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R76" id="__tag_298888350" rid="R76">76</a>]. The pro-emetic effects of two of these cannabinoids, CBD and CBG, have been discussed in this review and could conceivably play a role in the development of CHS. Additional pharmacological research is needed regarding the pro-emetic effects of additional cannabinoids and their metabolites. Another proposed explanation is that in susceptible individuals the pro-emetic effect of cannabis on the gut (e.g. delayed gastric emptying) overrides its anti-emetic CNS properties [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888368" rid="R62">62</a>]. This hypothesis is supported by the demonstration of delayed gastric emptying on gastric emptying scintigraphy in some cases [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888314" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R55" id="__tag_298888339" rid="R55">55</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888320" rid="R62">62</a>]. Further research is required to investigate the gastrointestinal physiology in these patients during both the acute attacks of hyperemesis and between episodes.</p><p class="p p-last" id="P24">A lack of long-term follow-up is also a major shortcoming in our knowledge of CHS. The majority of reported cases that have provided follow-up included a period of less than one year [<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_298888387" rid="R6">6</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R52" id="__tag_298888404" rid="R52">52</a>,<a class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R54" rid="R54">54</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R56" id="__tag_298888395" rid="R56">56</a>–<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R60" id="__tag_298888401" rid="R60">60</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_298888357" rid="R62">62</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R68" id="__tag_425411836" rid="R68">68</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R71" id="__tag_298888330" rid="R71">71</a>]. A greater understanding of the natural course of the syndrome and response to marijuana cessation may be gained with longer lengths of follow-up. Future studies following patients longitudinally for extended periods of time are needed.</p></div><div class="tsec sec" id="S11"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S11title">Conclusion</h2><p class="p p-first-last" id="P25">Cannabinoid Hyperemesis Syndrome is a new and under recognized clinical entity. Although its prevalence is unknown, numerous publications have preliminarily established its unique clinical characteristics. CHS should be considered as a plausible diagnosis in the setting of patients with recurrent intractable vomiting and strong history of cannabis abuse. Despite the well-established anti-emetic properties of marijuana, there is increasing evidence of its paradoxical effects on the gastrointestinal tract and CNS. Further initiatives are needed to determine this disease prevalence and its other epidemiological characteristics, natural history, and pathophysiology. Additional treatments are needed and efforts to discontinue cannabis abuse are paramount.</p></div><div class="tsec sec" id="idm139796978988784"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139796978988784title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health. <span class="ref-journal">ICPSR29621-v1.</span> Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor]; 2009.  2010-11-16. [<a href="//dx.doi.org/10.3886%2FICPSR29621" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI" target="pmc_ext">CrossRef</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?title=ICPSR29621-v1&amp;publication_year=2009&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Foley JD. Adolescent use and misuse of marijuana. <span><span class="ref-journal">Adolesc Med Clin. </span>2006;<span class="ref-vol">17</span>:319–34.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16814696" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Adolesc+Med+Clin&amp;title=Adolescent+use+and+misuse+of+marijuana&amp;author=JD+Foley&amp;volume=17&amp;publication_year=2006&amp;pages=319-34&amp;pmid=16814696&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">European Monitoring Centre of Drugs and Drug Addiction. <span class="ref-journal">Annual report 2006: the state of the drugs problem in Europe. Report No: 92-9168-266-7.</span> Office for Official Publications of the European Communities; Luxembourg:  <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?title=Annual+report+2006:+the+state+of+the+drugs+problem+in+Europe.+Report+No:+92-9168-266-7&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Compton WM, Grant BF, Colliver JD, et al.  Prevalence of marijuana use disorder in the United States: 1991–1992 and 2001–2002. <span><span class="ref-journal">JAMA. </span>2004;<span class="ref-vol">291</span>:2214–21.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Prevalence+of+marijuana+use+disorder+in+the+United+States:+1991–1992+and+2001–2002&amp;author=WM+Compton&amp;author=BF+Grant&amp;author=JD+Colliver&amp;volume=291&amp;publication_year=2004&amp;pages=2214-21&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Stinson FS, Ruan WJ, Pickering R, et al.  Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. <span><span class="ref-journal">Psychol Med. </span>2006;<span class="ref-vol">36</span>:1447–60.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16854249" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychol+Med&amp;title=Cannabis+use+disorders+in+the+USA:+prevalence,+correlates+and+co-morbidity&amp;author=FS+Stinson&amp;author=WJ+Ruan&amp;author=R+Pickering&amp;volume=36&amp;publication_year=2006&amp;pages=1447-60&amp;pmid=16854249&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Allen JH, de Moore GM, Heddle R, et al.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis use. <span><span class="ref-journal">Gut. </span>2004;<span class="ref-vol">53</span>:1566–1570.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774264/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15479672" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Cannabinoid+hyperemesis:+cyclical+hyperemesis+in+association+with+chronic+cannabis+use&amp;author=JH+Allen&amp;author=GM+de+Moore&amp;author=R+Heddle&amp;volume=53&amp;publication_year=2004&amp;pages=1566-1570&amp;pmid=15479672&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Howlett AC, Johnson MR, Melvin LS, et al.  Nonclassical Cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. <span><span class="ref-journal">Mol Pharmacol. </span>1988;<span class="ref-vol">33</span>:297–302.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/3352594" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=Nonclassical+Cannabinoid+analgetics+inhibit+adenylate+cyclase:+development+of+a+cannabinoid+receptor+model&amp;author=AC+Howlett&amp;author=MR+Johnson&amp;author=LS+Melvin&amp;volume=33&amp;publication_year=1988&amp;pages=297-302&amp;pmid=3352594&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Iverson L. Cannabis and the brain. <span><span class="ref-journal">Brain. </span>2003;<span class="ref-vol">126</span>:1252–70.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12764049" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Cannabis+and+the+brain&amp;author=L+Iverson&amp;volume=126&amp;publication_year=2003&amp;pages=1252-70&amp;pmid=12764049&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. <span><span class="ref-journal">Gut. </span>2008;<span class="ref-vol">57</span>:1140–55.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18397936" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Emerging+role+of+cannabinoids+in+gastrointestinal+and+liver+diseases:+basic+and+clinical+aspects&amp;author=AA+Izzo&amp;author=M+Camilleri&amp;volume=57&amp;publication_year=2008&amp;pages=1140-55&amp;pmid=18397936&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. <span><span class="ref-journal">Pharmacol Ther. </span>1997;<span class="ref-vol">74</span>:129–80.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9336020" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;title=Pharmacology+of+cannabinoid+CB1+and+CB2+receptors&amp;author=RG+Pertwee&amp;volume=74&amp;publication_year=1997&amp;pages=129-80&amp;pmid=9336020&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Pertwee RG. Pharmacology of cannabinoid receptor ligands. <span><span class="ref-journal">Curr Med Chem. </span>1999;<span class="ref-vol">6</span>:635–64.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10469884" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Curr+Med+Chem&amp;title=Pharmacology+of+cannabinoid+receptor+ligands&amp;author=RG+Pertwee&amp;volume=6&amp;publication_year=1999&amp;pages=635-64&amp;pmid=10469884&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Wright K, Rooney N, Feeney M, et al.  Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. <span><span class="ref-journal">Gastroenterology. </span>2005;<span class="ref-vol">129</span>:437–53.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16083701" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Differential+expression+of+cannabinoid+receptors+in+the+human+colon:+cannabinoids+promote+epithelial+wound+healing&amp;author=K+Wright&amp;author=N+Rooney&amp;author=M+Feeney&amp;volume=129&amp;publication_year=2005&amp;pages=437-53&amp;pmid=16083701&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Wright KL, Duncan M, Sharkey KA. Cannabinoid CB(2) receptors in the gastrointestinal tract: a regulatory system in states of inflammation. <span><span class="ref-journal">Br J Pharmacol. </span>2008;<span class="ref-vol">153</span>:263–70.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17906675" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Cannabinoid+CB(2)+receptors+in+the+gastrointestinal+tract:+a+regulatory+system+in+states+of+inflammation&amp;author=KL+Wright&amp;author=M+Duncan&amp;author=KA+Sharkey&amp;volume=153&amp;publication_year=2008&amp;pages=263-70&amp;pmid=17906675&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Mathison R, Ho W, Pittman QJ, et al.  Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. <span><span class="ref-journal">Br J Pharmacol. </span>2004;<span class="ref-vol">142</span>:1247–54.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575196/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15249429" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Effects+of+cannabinoid+receptor-2+activation+on+accelerated+gastrointestinal+transit+in+lipopolysaccharide-treated+rats&amp;author=R+Mathison&amp;author=W+Ho&amp;author=QJ+Pittman&amp;volume=142&amp;publication_year=2004&amp;pages=1247-54&amp;pmid=15249429&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system. <span><span class="ref-journal">Aliment Pharmacol Ther. </span>2005;<span class="ref-vol">22</span>:667–83.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16197488" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Aliment+Pharmacol+Ther&amp;title=Review+article:+endocannabinoids+and+their+receptors+in+the+enteric+nervous+system&amp;author=M+Duncan&amp;author=JS+Davison&amp;author=KA+Sharkey&amp;volume=22&amp;publication_year=2005&amp;pages=667-83&amp;pmid=16197488&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Cadas H, di Tomaso E, Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursors, N-arachidonoyl phosphatidylethanolamine, in rat brains. <span><span class="ref-journal">J Neurosci. </span>1997;<span class="ref-vol">17</span>:1226–42.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9006968" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=Occurrence+and+biosynthesis+of+endogenous+cannabinoid+precursors,+N-arachidonoyl+phosphatidylethanolamine,+in+rat+brains&amp;author=H+Cadas&amp;author=E+di+Tomaso&amp;author=D+Piomelli&amp;volume=17&amp;publication_year=1997&amp;pages=1226-42&amp;pmid=9006968&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">DiMarzo V, Fontana A, Cadas H, et al.  Formation and inactivation of endogenous cannabinoid anandamide in central neurons. <span><span class="ref-journal">Nature. </span>1994;<span class="ref-vol">372</span>:686–91.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7990962" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Formation+and+inactivation+of+endogenous+cannabinoid+anandamide+in+central+neurons&amp;author=V+DiMarzo&amp;author=A+Fontana&amp;author=H+Cadas&amp;volume=372&amp;publication_year=1994&amp;pages=686-91&amp;pmid=7990962&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Giuffrida A, Beltramo M, Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2001;<span class="ref-vol">298</span>:7–14.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11408519" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Mechanisms+of+endocannabinoid+inactivation:+biochemistry+and+pharmacology&amp;author=A+Giuffrida&amp;author=M+Beltramo&amp;author=D+Piomelli&amp;volume=298&amp;publication_year=2001&amp;pages=7-14&amp;pmid=11408519&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Watanabe K, Matsunaga T, Yamamoto I, et al.  Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman. <span><span class="ref-journal">Biol Pharm Bull. </span>1995;<span class="ref-vol">18</span>:1138–41.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8535411" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Biol+Pharm+Bull&amp;title=Involvement+of+CYP2C+in+the+metabolism+of+cannabinoids+by+human+hepatic+microsomes+from+an+old+woman&amp;author=K+Watanabe&amp;author=T+Matsunaga&amp;author=I+Yamamoto&amp;volume=18&amp;publication_year=1995&amp;pages=1138-41&amp;pmid=8535411&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. <span><span class="ref-journal">Clin Pharmacokinet. </span>2003;<span class="ref-vol">42</span>:327–60.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12648025" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacokinet&amp;title=Pharmacokinetics+and+pharmacodynamics+of+cannabinoids&amp;author=F+Grotenhermen&amp;volume=42&amp;publication_year=2003&amp;pages=327-60&amp;pmid=12648025&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Wall ME, Sadler BM, Brine D, et al.  Metabolism, disposition, and kinetics of delta-9 tetrahydrocannabinol, in men and women. <span><span class="ref-journal">Clin Pharmacol Ther. </span>1983;<span class="ref-vol">34</span>:352–63.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Metabolism,+disposition,+and+kinetics+of+delta-9+tetrahydrocannabinol,+in+men+and+women&amp;author=ME+Wall&amp;author=BM+Sadler&amp;author=D+Brine&amp;volume=34&amp;publication_year=1983&amp;pages=352-63&amp;pmid=6309462&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Kreuz DS, Axelrod J. Delta-9-tetrahydrocannabinol: localization in body fat. <span><span class="ref-journal">Science. </span>1973;<span class="ref-vol">179</span>:391–3.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/4682965" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Delta-9-tetrahydrocannabinol:+localization+in+body+fat&amp;author=DS+Kreuz&amp;author=J+Axelrod&amp;volume=179&amp;publication_year=1973&amp;pages=391-3&amp;pmid=4682965&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Gunasekaran N, Long LE, Dawson BL, et al.  Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. <span><span class="ref-journal">Br J Pharmacol. </span>2009;<span class="ref-vol">158</span>:1330–7.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782342/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19681888" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Reintoxication:+the+release+of+fat-stored+delta(9)-tetrahydrocannabinol+(THC)+into+blood+is+enhanced+by+food+deprivation+or+ACTH+exposure&amp;author=N+Gunasekaran&amp;author=LE+Long&amp;author=BL+Dawson&amp;volume=158&amp;publication_year=2009&amp;pages=1330-7&amp;pmid=19681888&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Harvey DJ, Brown NK. Comparative in vitro metabolism of the cannabinoids. <span><span class="ref-journal">Pharmacol Biochem Behav. </span>1991;<span class="ref-vol">40</span>:533–40.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/1806943" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;title=Comparative+in+vitro+metabolism+of+the+cannabinoids&amp;author=DJ+Harvey&amp;author=NK+Brown&amp;volume=40&amp;publication_year=1991&amp;pages=533-40&amp;pmid=1806943&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Perez-Reyes M, Timmons M, Lipton M, et al.  Intravenous injection in man of delta-9-tetrahydro-cannabinol and 11-OH-delta-9-tetrahydrocannabinol. <span><span class="ref-journal">Science. </span>1972;<span class="ref-vol">177</span>:633–5.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/4558903" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Intravenous+injection+in+man+of+delta-9-tetrahydro-cannabinol+and+11-OH-delta-9-tetrahydrocannabinol&amp;author=M+Perez-Reyes&amp;author=M+Timmons&amp;author=M+Lipton&amp;volume=177&amp;publication_year=1972&amp;pages=633-5&amp;pmid=4558903&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Burstein SH. The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. <span><span class="ref-journal">Pharmacol Ther. </span>1999;<span class="ref-vol">82</span>:87–96.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10341359" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;title=The+cannabinoid+acids:+nonpsychoactive+derivatives+with+therapeutic+potential&amp;author=SH+Burstein&amp;volume=82&amp;publication_year=1999&amp;pages=87-96&amp;pmid=10341359&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Mechoulam R, Parker LA, Gallily R. Cannabidiol: an overview of some pharmacological aspects. <span><span class="ref-journal">J Clin Pharmacol. </span>2002;<span class="ref-vol">42</span>:11–19.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12412831" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;title=Cannabidiol:+an+overview+of+some+pharmacological+aspects&amp;author=R+Mechoulam&amp;author=LA+Parker&amp;author=R+Gallily&amp;volume=42&amp;publication_year=2002&amp;pages=11-19&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Russo EB, Burnett A, Hall B, et al.  Agonistic properties of Cannabidiol at 5-HT1a receptors. <span><span class="ref-journal">Neurochem Res. </span>2005;<span class="ref-vol">30</span>:1037–43.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16258853" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurochem+Res&amp;title=Agonistic+properties+of+Cannabidiol+at+5-HT1a+receptors&amp;author=EB+Russo&amp;author=A+Burnett&amp;author=B+Hall&amp;volume=30&amp;publication_year=2005&amp;pages=1037-43&amp;pmid=16258853&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Hayakawa K, Mishima K, Hazekawa M, et al.  Cannabidiol potentiates pharmacologic effects of Δ 9 -tetrahydrocannabinol via CB1 receptor-dependent mechanism. <span><span class="ref-journal">Brain Res. </span>2008;<span class="ref-vol">1188</span>:157–164.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18021759" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;title=Cannabidiol+potentiates+pharmacologic+effects+of+Δ+9+-tetrahydrocannabinol+via+CB1+receptor-dependent+mechanism&amp;author=K+Hayakawa&amp;author=K+Mishima&amp;author=M+Hazekawa&amp;volume=1188&amp;publication_year=2008&amp;pages=157-164&amp;pmid=18021759&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Parker LA, Kwiatkowska M, Burton P, et al.  Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus(house musk shrew) <span><span class="ref-journal">Psychopharmacology. </span>2004;<span class="ref-vol">171</span>:156–61.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/13680081" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Effect+of+cannabinoids+on+lithium-induced+vomiting+in+the+Suncus+murinus(house+musk+shrew)&amp;author=LA+Parker&amp;author=M+Kwiatkowska&amp;author=P+Burton&amp;volume=171&amp;publication_year=2004&amp;pages=156-61&amp;pmid=13680081&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Kwiatkowska M, Parker LA, Burton P, et al.  A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew) <span><span class="ref-journal">Psychopharmacology. </span>2004;<span class="ref-vol">174</span>:254–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/14740147" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=A+comparative+analysis+of+the+potential+of+cannabinoids+and+ondansetron+to+suppress+cisplatin-induced+emesis+in+the+Suncus+murinus+(house+musk+shrew)&amp;author=M+Kwiatkowska&amp;author=LA+Parker&amp;author=P+Burton&amp;volume=174&amp;publication_year=2004&amp;pages=254-9&amp;pmid=14740147&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Cascio MG, Gauson LA, Stevenson LA, et al.  Evidence that the plant cannabinoid cannabigerol is a highly potent alpha 2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. <span><span class="ref-journal">Br J Pharmacol. </span>2010;<span class="ref-vol">159</span>:129–41.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823359/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20002104" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Evidence+that+the+plant+cannabinoid+cannabigerol+is+a+highly+potent+alpha+2-adrenoceptor+agonist+and+moderately+potent+5HT1A+receptor+antagonist&amp;author=MG+Cascio&amp;author=LA+Gauson&amp;author=LA+Stevenson&amp;volume=159&amp;publication_year=2010&amp;pages=129-41&amp;pmid=20002104&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Rock EM, Goodwin JM, Limebeer CL, et al.  Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. <span><span class="ref-journal">Psychopharmacology. </span>2011</span> [Epub ahead of print] [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21243485" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Interaction+between+non-psychotropic+cannabinoids+in+marihuana:+effect+of+cannabigerol+(CBG)+on+the+anti-nausea+or+anti-emetic+effects+of+cannabidiol+(CBD)+in+rats+and+shrews&amp;author=EM+Rock&amp;author=JM+Goodwin&amp;author=CL+Limebeer&amp;publication_year=2011&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Pi-Sunyer FX, Aronne LJ, Heshmati HM, et al.  Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. <span><span class="ref-journal">JAMA. </span>2006;<span class="ref-vol">295</span>:761–75.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16478899" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Effect+of+rimonabant,+a+cannabinoid-1+receptor+blocker,+on+weight+and+cardiometabolic+risk+factors+in+overweight+or+obese+patients:+RIO-North+America:+a+randomized+controlled+trial&amp;author=FX+Pi-Sunyer&amp;author=LJ+Aronne&amp;author=HM+Heshmati&amp;volume=295&amp;publication_year=2006&amp;pages=761-75&amp;pmid=16478899&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Darmani NA. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol), are blocked by delta (9)-tetrahydrocannabinol and other cannabinoids. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2002;<span class="ref-vol">300</span>:34–42.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11752094" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=The+potent+emetogenic+effects+of+the+endocannabinoid,+2-AG+(2-arachidonoylglycerol),+are+blocked+by+delta+(9)-tetrahydrocannabinol+and+other+cannabinoids&amp;author=NA+Darmani&amp;volume=300&amp;publication_year=2002&amp;pages=34-42&amp;pmid=11752094&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Van Sickle MD, Oland LD, Ho W, et al.  Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. <span><span class="ref-journal">Gastroenterology. </span>2001;<span class="ref-vol">121</span>:767–74.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11606489" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Cannabinoids+inhibit+emesis+through+CB1+receptors+in+the+brainstem+of+the+ferret&amp;author=MD+Van+Sickle&amp;author=LD+Oland&amp;author=W+Ho&amp;volume=121&amp;publication_year=2001&amp;pages=767-74&amp;pmid=11606489&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Walsh D, Nelson KA, Mahmoud FA. Established and potential therapeutic applications of cannabinoids in oncology. <span><span class="ref-journal">Support Care Cancer. </span>2003;<span class="ref-vol">11</span>:137–43.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12618922" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Support+Care+Cancer&amp;title=Established+and+potential+therapeutic+applications+of+cannabinoids+in+oncology&amp;author=D+Walsh&amp;author=KA+Nelson&amp;author=FA+Mahmoud&amp;volume=11&amp;publication_year=2003&amp;pages=137-43&amp;pmid=12618922&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Pagotto U, Marsicano G, Cota D, et al.  The emerging role of the endocannabinoid system in endocrine regulation and energy balance. <span><span class="ref-journal">Endocr Rev. </span>2006;<span class="ref-vol">27</span>:73–100.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16306385" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=The+emerging+role+of+the+endocannabinoid+system+in+endocrine+regulation+and+energy+balance&amp;author=U+Pagotto&amp;author=G+Marsicano&amp;author=D+Cota&amp;volume=27&amp;publication_year=2006&amp;pages=73-100&amp;pmid=16306385&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Cota D, Steiner MA, Marsicano G, et al.  Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. <span><span class="ref-journal">Endocrinology. </span>2007;<span class="ref-vol">148</span>:1574–81.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17194743" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Requirement+of+cannabinoid+receptor+type+1+for+the+basal+modulation+of+hypothalamic-pituitary-adrenal+axis+function&amp;author=D+Cota&amp;author=MA+Steiner&amp;author=G+Marsicano&amp;volume=148&amp;publication_year=2007&amp;pages=1574-81&amp;pmid=17194743&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Lehmann A, Blackshaw LA, Brandon L, et al.  Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxation and reflux in dogs. <span><span class="ref-journal">Gastroenterology. </span>2002;<span class="ref-vol">123</span>:1129–34.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12360475" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Cannabinoid+receptor+agonism+inhibits+transient+lower+esophageal+sphincter+relaxation+and+reflux+in+dogs&amp;author=A+Lehmann&amp;author=LA+Blackshaw&amp;author=L+Brandon&amp;volume=123&amp;publication_year=2002&amp;pages=1129-34&amp;pmid=12360475&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Hinds NM, Ullrich K, Smid SD. Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon. <span><span class="ref-journal">Br J Pharmacol. </span>2006;<span class="ref-vol">148</span>:191–99.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1617060/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16520743" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Cannabinoid+1+(CB1)+receptors+coupled+to+cholinergic+motorneurones+inhibit+neurogenic+circular+muscle+contractility+in+the+human+colon&amp;author=NM+Hinds&amp;author=K+Ullrich&amp;author=SD+Smid&amp;volume=148&amp;publication_year=2006&amp;pages=191-99&amp;pmid=16520743&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Esfandyari T, Camilleri M, Busciglio I, et al.  Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. <span><span class="ref-journal">Am J Physiol Gastrointest Liver Physiol. </span>2007;<span class="ref-vol">293</span>:137–45.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17395895" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Gastrointest+Liver+Physiol&amp;title=Effects+of+a+cannabinoid+receptor+agonist+on+colonic+motor+and+sensory+functions+in+humans:+a+randomized,+placebo-controlled+study&amp;author=T+Esfandyari&amp;author=M+Camilleri&amp;author=I+Busciglio&amp;volume=293&amp;publication_year=2007&amp;pages=137-45&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Pertwee RG. Cannabinoids and the gastrointestinal tract. <span><span class="ref-journal">Gut. </span>2001;<span class="ref-vol">48</span>:859–67.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1728337/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11358910" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Cannabinoids+and+the+gastrointestinal+tract&amp;author=RG+Pertwee&amp;volume=48&amp;publication_year=2001&amp;pages=859-67&amp;pmid=11358910&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Krowicki ZK, Moerschbaecher JM, Winsauer PJ, et al.  Delta9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors. <span><span class="ref-journal">Eur J Pharmacol. </span>1999;<span class="ref-vol">371</span>:187–96.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10357256" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;title=Delta9-tetrahydrocannabinol+inhibits+gastric+motility+in+the+rat+through+cannabinoid+CB1+receptors&amp;author=ZK+Krowicki&amp;author=JM+Moerschbaecher&amp;author=PJ+Winsauer&amp;volume=371&amp;publication_year=1999&amp;pages=187-96&amp;pmid=10357256&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">Izzo AA, Mascolo N, Capasso R, et al.  Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. <span><span class="ref-journal">Naunyn Schmiedebergs Arch Pharmacol. </span>1999;<span class="ref-vol">360</span>:221–3.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10494894" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Naunyn+Schmiedebergs+Arch+Pharmacol&amp;title=Inhibitory+effect+of+cannabinoid+agonists+on+gastric+emptying+in+the+rat&amp;author=AA+Izzo&amp;author=N+Mascolo&amp;author=R+Capasso&amp;volume=360&amp;publication_year=1999&amp;pages=221-3&amp;pmid=10494894&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">McCallum RW, Soykan I, Sridhar KR, et al.  Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. <span><span class="ref-journal">Aliment Pharmacol Ther. </span>1999;<span class="ref-vol">13</span>:77–80.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9892882" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Aliment+Pharmacol+Ther&amp;title=Delta-9-tetrahydrocannabinol+delays+the+gastric+emptying+of+solid+food+in+humans:+a+double-blind,+randomized+study&amp;author=RW+McCallum&amp;author=I+Soykan&amp;author=KR+Sridhar&amp;volume=13&amp;publication_year=1999&amp;pages=77-80&amp;pmid=9892882&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">Esfandyari T, Camilleri M, Ferber I, et al.  Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. <span><span class="ref-journal">Neurogastroenterol Motil. </span>2006;<span class="ref-vol">18</span>:831–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16918762" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurogastroenterol+Motil&amp;title=Effect+of+a+cannabinoid+agonist+on+gastrointestinal+transit+and+postprandial+satiation+in+healthy+human+subjects:+a+randomized,+placebo-controlled+study&amp;author=T+Esfandyari&amp;author=M+Camilleri&amp;author=I+Ferber&amp;volume=18&amp;publication_year=2006&amp;pages=831-8&amp;pmid=16918762&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="element-citation">Abalo R, Cabezos PA, Lopez-Miranda V, et al.  Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat. <span><span class="ref-journal">Neurogastroenterol Motil. </span>2009;<span class="ref-vol">21</span>:1002–80.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19413685" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurogastroenterol+Motil&amp;title=Selective+lack+of+tolerance+to+delayed+gastric+emptying+after+daily+administration+of+WIN+55,212-2+in+the+rat&amp;author=R+Abalo&amp;author=PA+Cabezos&amp;author=V+Lopez-Miranda&amp;volume=21&amp;publication_year=2009&amp;pages=1002-80&amp;pmid=19413685&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="element-citation">Abalo R, Cabezos PA, Vera G, et al.  Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors. <span><span class="ref-journal">Neurogastroenterol Motil. </span>2011;<span class="ref-vol">23</span>:457–77.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21303434" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurogastroenterol+Motil&amp;title=Cannabinoid-induced+delayed+gastric+emptying+is+selectively+increased+upon+intermittent+administration+in+the+rat:+role+of+CB1+receptors&amp;author=R+Abalo&amp;author=PA+Cabezos&amp;author=G+Vera&amp;volume=23&amp;publication_year=2011&amp;pages=457-77&amp;pmid=21303434&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">50. <span class="element-citation">Parkman HP, Fass R, Foxx-Orenstein AE. Treatment of patients with diabetic gastroparesis. <span><span class="ref-journal">Gastroenterol Hepatol. </span>2010;<span class="ref-vol">6</span>:1–16.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920593/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20733935" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gastroenterol+Hepatol&amp;title=Treatment+of+patients+with+diabetic+gastroparesis&amp;author=HP+Parkman&amp;author=R+Fass&amp;author=AE+Foxx-Orenstein&amp;volume=6&amp;publication_year=2010&amp;pages=1-16&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R51">51. <span class="element-citation">Roche E, Foster PN. Cannabinoid hyperemesis: not just a problem in Adelaide Hills. <span><span class="ref-journal">Gut. </span>2005;<span class="ref-vol">54</span>:731.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774504/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15831930" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Cannabinoid+hyperemesis:+not+just+a+problem+in+Adelaide+Hills&amp;author=E+Roche&amp;author=PN+Foster&amp;volume=54&amp;publication_year=2005&amp;pages=731&amp;pmid=15831930&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R52">52. <span class="element-citation">Singh E, Coyle W. Cannabinoid hyperemesis. <span><span class="ref-journal">Am J Gastroenterol. </span>2008;<span class="ref-vol">103</span>:1048–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18397435" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;title=Cannabinoid+hyperemesis&amp;author=E+Singh&amp;author=W+Coyle&amp;volume=103&amp;publication_year=2008&amp;pages=1048-9&amp;pmid=18397435&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R53">53. <span class="element-citation">Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. <span><span class="ref-journal">Aust Psychiatry. </span>2007;<span class="ref-vol">15</span>:156–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17464661" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Aust+Psychiatry&amp;title=Cannabinoid+hyperemesis:+marijuana+puts+patients+in+hot+water&amp;author=D+Wallace&amp;author=AL+Martin&amp;author=B+Park&amp;volume=15&amp;publication_year=2007&amp;pages=156-8&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R54">54. <span class="element-citation">Budhraja V, Narang T, Slaiman A. Cannabinoid hyperemesis syndrome: cyclic vomiting, chronic cannabis use and compulsive bathing. <span><span class="ref-journal">Practical Gastroeneterol. </span>2008;<span class="ref-vol">32</span>:79–80.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Practical+Gastroeneterol&amp;title=Cannabinoid+hyperemesis+syndrome:+cyclic+vomiting,+chronic+cannabis+use+and+compulsive+bathing&amp;author=V+Budhraja&amp;author=T+Narang&amp;author=A+Slaiman&amp;volume=32&amp;publication_year=2008&amp;pages=79-80&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R55">55. <span class="element-citation">Chang YH, Windish D. Cannabinoid hyperemesis relieved by compulsive bathing. <span><span class="ref-journal">Mayo Clin Proc. </span>2009;<span class="ref-vol">84</span>:76–78.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664574/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19121257" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mayo+Clin+Proc&amp;title=Cannabinoid+hyperemesis+relieved+by+compulsive+bathing&amp;author=YH+Chang&amp;author=D+Windish&amp;volume=84&amp;publication_year=2009&amp;pages=76-78&amp;pmid=19121257&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R56">56. <span class="element-citation">Sannarangappa V, Tan C. Cannabinoid hyperemesis. <span><span class="ref-journal">Intern Med J. </span>2009;<span class="ref-vol">39</span>:777–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19912406" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Intern+Med+J&amp;title=Cannabinoid+hyperemesis&amp;author=V+Sannarangappa&amp;author=C+Tan&amp;volume=39&amp;publication_year=2009&amp;pages=777-8&amp;pmid=19912406&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R57">57. <span class="element-citation">Sontineni SP, Chaudhary S, Sontineni V, et al.  Cannabinoid hyperemesis syndrome: clinical diagnosis of an under recognized manifestation of chronic cannabis abuse. <span><span class="ref-journal">World J Gastroenterol. </span>2009;<span class="ref-vol">15</span>:1264–6.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658859/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19291829" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Cannabinoid+hyperemesis+syndrome:+clinical+diagnosis+of+an+under+recognized+manifestation+of+chronic+cannabis+abuse&amp;author=SP+Sontineni&amp;author=S+Chaudhary&amp;author=V+Sontineni&amp;volume=15&amp;publication_year=2009&amp;pages=1264-6&amp;pmid=19291829&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R58">58. <span class="element-citation">Watts M. Cannabinoid hyperemesis presenting to a New Zealand hospital. <span><span class="ref-journal">N Z Med J. </span>2009;<span class="ref-vol">122</span>:116–8.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19319174" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=N+Z+Med+J&amp;title=Cannabinoid+hyperemesis+presenting+to+a+New+Zealand+hospital&amp;author=M+Watts&amp;volume=122&amp;publication_year=2009&amp;pages=116-8&amp;pmid=19319174&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R59">59. <span class="element-citation">Donnino MW, Cocchi MN, Miller J, et al.  Cannabinoid hyperemesis: a case series. <span><span class="ref-journal">J Emerg Med. </span>2009;<span class="ref-vol">40</span>:63–6.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19765941" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Emerg+Med&amp;title=Cannabinoid+hyperemesis:+a+case+series&amp;author=MW+Donnino&amp;author=MN+Cocchi&amp;author=J+Miller&amp;volume=40&amp;publication_year=2009&amp;pages=63-6&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R60">60. <span class="element-citation">Miller JB, Walsh M, Patel PA, et al.  Pediatric cannabinoid hyperemesis: two cases. <span><span class="ref-journal">Pediatr Emerg Care. </span>2010;<span class="ref-vol">26</span>:919–20.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21131803" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Emerg+Care&amp;title=Pediatric+cannabinoid+hyperemesis:+two+cases&amp;author=JB+Miller&amp;author=M+Walsh&amp;author=PA+Patel&amp;volume=26&amp;publication_year=2010&amp;pages=919-20&amp;pmid=21131803&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R61">61. <span class="element-citation">Patterson DA, Smith E, Monahan M, et al.  Cannabinoid hyperemesis and compulsive bathing: a case series and paradoxical pathophysiological explanation. <span><span class="ref-journal">J Am Board Fam Med. </span>2010;<span class="ref-vol">23</span>:790–3.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21057076" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Am+Board+Fam+Med&amp;title=Cannabinoid+hyperemesis+and+compulsive+bathing:+a+case+series+and+paradoxical+pathophysiological+explanation&amp;author=DA+Patterson&amp;author=E+Smith&amp;author=M+Monahan&amp;volume=23&amp;publication_year=2010&amp;pages=790-3&amp;pmid=21057076&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R62">62. <span class="element-citation">Soriano-Co M, Batke M, Cappell MS. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States. <span><span class="ref-journal">Dig Dis Sci. </span>2010;<span class="ref-vol">55</span>:3113–9.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20130993" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Dig+Dis+Sci&amp;title=The+cannabis+hyperemesis+syndrome+characterized+by+persistent+nausea+and+vomiting,+abdominal+pain,+and+compulsive+bathing+associated+with+chronic+marijuana+use:+a+report+of+eight+cases+in+the+United+States&amp;author=M+Soriano-Co&amp;author=M+Batke&amp;author=MS+Cappell&amp;volume=55&amp;publication_year=2010&amp;pages=3113-9&amp;pmid=20130993&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R63">63. <span class="element-citation">Quigley E, Hasler W, Parkman H. AGA Technical review on nausea and vomiting. <span><span class="ref-journal">Gastroenterology. </span>2001;<span class="ref-vol">120</span>:263–86.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11208736" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=AGA+Technical+review+on+nausea+and+vomiting&amp;author=E+Quigley&amp;author=W+Hasler&amp;author=H+Parkman&amp;volume=120&amp;publication_year=2001&amp;pages=263-86&amp;pmid=11208736&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R64">64. <span class="element-citation">Abell TL, Kim CH, Malagelada JR. Idiopathic cyclic nausea and vomiting—a disorder of gastrointestinal motility. <span><span class="ref-journal">Mayo Clin Proc. </span>1988;<span class="ref-vol">63</span>:1169–1175.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/3199884" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mayo+Clin+Proc&amp;title=Idiopathic+cyclic+nausea+and+vomiting—a+disorder+of+gastrointestinal+motility&amp;author=TL+Abell&amp;author=CH+Kim&amp;author=JR+Malagelada&amp;volume=63&amp;publication_year=1988&amp;pages=1169-1175&amp;pmid=3199884&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R65">65. <span class="element-citation">Namin F, Patel J, Lin Z, Sarosiek I, Foran P, Esmaeili P, et al.  Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy. <span><span class="ref-journal">Neurogastroenterol Motility. </span>2007;<span class="ref-vol">19</span>:196–202.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17300289" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Neurogastroenterol+Motility&amp;title=Clinical,+psychiatric+and+manometric+profile+of+cyclic+vomiting+syndrome+in+adults+and+response+to+tricyclic+therapy&amp;author=F+Namin&amp;author=J+Patel&amp;author=Z+Lin&amp;author=I+Sarosiek&amp;author=P+Foran&amp;volume=19&amp;publication_year=2007&amp;pages=196-202&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R66">66. <span class="element-citation">Hejazi RA, Reddymasu SC, Namin F, Lavenbarg T, Foran P, McCallum RW. Efficacy of tricyclic antidepressant therapy in adults with cyclic vomiting syndrome: a two-year follow-up study. <span><span class="ref-journal">J Clin Gastroenterol. </span>2010;<span class="ref-vol">44</span>:18–21.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20027010" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Gastroenterol&amp;title=Efficacy+of+tricyclic+antidepressant+therapy+in+adults+with+cyclic+vomiting+syndrome:+a+two-year+follow-up+study&amp;author=RA+Hejazi&amp;author=SC+Reddymasu&amp;author=F+Namin&amp;author=T+Lavenbarg&amp;author=P+Foran&amp;volume=44&amp;publication_year=2010&amp;pages=18-21&amp;pmid=20027010&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R67">67. <span class="element-citation">Tack J, Talley N, Camilleri M, et al.  Functional Gastroduodenal Disorders. <span><span class="ref-journal">Gastroenterology. </span>2006;<span class="ref-vol">130</span>:1466–79.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16678560" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Functional+Gastroduodenal+Disorders&amp;author=J+Tack&amp;author=N+Talley&amp;author=M+Camilleri&amp;volume=130&amp;publication_year=2006&amp;pages=1466-79&amp;pmid=16678560&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R68">68. <span class="element-citation">Schmid SM, Lapaire O, Huang DJ, et al.  Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy. <span><span class="ref-journal">Arch Gynecol Obstet. </span>2010</span> [Epub ahead of print] [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21170540" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Arch+Gynecol+Obstet&amp;title=Cannabinoid+hyperemesis+syndrome:+an+underreported+entity+causing+nausea+and+vomiting+of+pregnancy&amp;author=SM+Schmid&amp;author=O+Lapaire&amp;author=DJ+Huang&amp;publication_year=2010&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R69">69. <span class="element-citation">Porreca F, Ossipov MH. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. <span><span class="ref-journal">Pain Med. </span>2009;<span class="ref-vol">10</span>:654–62.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19302436" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pain+Med&amp;title=Nausea+and+vomiting+side+effects+with+opioid+analgesics+during+treatment+of+chronic+pain:+mechanisms,+implications,+and+management+options&amp;author=F+Porreca&amp;author=MH+Ossipov&amp;volume=10&amp;publication_year=2009&amp;pages=654-62&amp;pmid=19302436&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R70">70. <span class="element-citation">Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL. Side effects of opioids during short-term administration: effect of age, gender, and race. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2003;<span class="ref-vol">74</span>:102–12.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12891220" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Side+effects+of+opioids+during+short-term+administration:+effect+of+age,+gender,+and+race&amp;author=MS+Cepeda&amp;author=JT+Farrar&amp;author=M+Baumgarten&amp;author=R+Boston&amp;author=DB+Carr&amp;volume=74&amp;publication_year=2003&amp;pages=102-12&amp;pmid=12891220&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R71">71. <span class="element-citation">Chepyala P, Olden KW. Cyclic vomiting and compulsive bathing with chronic cannabis abuse. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2008;<span class="ref-vol">6</span>:710–12.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18456571" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Gastroenterol+Hepatol&amp;title=Cyclic+vomiting+and+compulsive+bathing+with+chronic+cannabis+abuse&amp;author=P+Chepyala&amp;author=KW+Olden&amp;volume=6&amp;publication_year=2008&amp;pages=710-12&amp;pmid=18456571&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R72">72. <span class="element-citation">Darmani NA. Cannabinoid-induced hyperemesis: A conundrum-from clinical recognition to basic science mechanisms. <span><span class="ref-journal">Pharmaceuticals. </span>2010;<span class="ref-vol">3</span>:2163–77.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036650/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/27713347" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Cannabinoid-induced+hyperemesis:+A+conundrum-from+clinical+recognition+to+basic+science+mechanisms&amp;author=NA+Darmani&amp;volume=3&amp;publication_year=2010&amp;pages=2163-77&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R73">73. <span class="element-citation">Budney AJ, Roffman R, Stephens RS, et al.  Marijuana dependence and its treatment. <span><span class="ref-journal">Addict Sci Clin Pract. </span>2007;<span class="ref-vol">4</span>:4–16.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797098/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18292704" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Addict+Sci+Clin+Pract&amp;title=Marijuana+dependence+and+its+treatment&amp;author=AJ+Budney&amp;author=R+Roffman&amp;author=RS+Stephens&amp;volume=4&amp;publication_year=2007&amp;pages=4-16&amp;pmid=18292704&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R74">74. <span class="element-citation">Budhraja V. Confirming the diagnosis of cannabinoid hyperemesis syndrome. <span><span class="ref-journal">Mayo Clin Proc. </span>2009;<span class="ref-vol">84</span>:483.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19411446" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mayo+Clin+Proc&amp;title=Confirming+the+diagnosis+of+cannabinoid+hyperemesis+syndrome&amp;author=V+Budhraja&amp;volume=84&amp;publication_year=2009&amp;pages=483&amp;pmid=19411446&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R75">75. <span class="element-citation">Byrne A, Hallinan R, Wodak A. Cannabis hyperemesis causation questioned. <span><span class="ref-journal">Gut. </span>2006;<span class="ref-vol">55</span>:132.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856368/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16344581" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Cannabis+hyperemesis+causation+questioned&amp;author=A+Byrne&amp;author=R+Hallinan&amp;author=A+Wodak&amp;volume=55&amp;publication_year=2006&amp;pages=132&amp;pmid=16344581&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R76">76. <span class="element-citation">Watson SJ, Benson JA, Joy JE. Marijuana and Medicine: assessing the science base: a summary of the 1999 Institute of Medicine Report. <span><span class="ref-journal">Arch Gen Psychiat. </span>2000;<span class="ref-vol">57</span>:547–52.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10839332" ref="reftype=pubmed&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiat&amp;title=Marijuana+and+Medicine:+assessing+the+science+base:+a+summary+of+the+1999+Institute+of+Medicine+Report&amp;author=SJ+Watson&amp;author=JA+Benson&amp;author=JE+Joy&amp;volume=57&amp;publication_year=2000&amp;pages=547-52&amp;pmid=10839332&amp;" ref="reftype=other&amp;article-id=3576702&amp;issue-id=219807&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div></div></div><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu" style="display: none; width: 200px; top: -100px; left: -100px;"><ul id="ui-ncbiinpagenav-2"><li><a href="https://www.ncbi.nlm.nih.gov/#idm139796978612832title">Abstract</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S1title">Epidemiology and Introduction</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S2title">Pharmacology of Cannabinoids</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S8title">Clinical Presentation, work up and differential diagnosis of Cannabinoid Hyperemesis Syndrome</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S9title">Treatment</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S10title">Shortcomings in our knowledge of CHS and areas for future research</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S11title">Conclusion</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm139796978988784title">References</a></li></ul></div></div></div>
</div>
</div>
<div class="four_col col last" id="rightcolumn">
<div class="col6">
</div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702//pmc/articles/PMC3576702/epub/">ePub (beta)</a></li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/pdf/nihms353647.pdf">PDF (911K)</a></li> | <li><a aria-expanded="false" aria-haspopup="true" class="citationexporter ctxp" data-citationid="PMC3576702" href="https://www.ncbi.nlm.nih.gov/#" role="button">Citation</a></li></ul></div></div><div class="share-buttons" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><h2>Share</h2><ul><li class="facebook"><a aria-expanded="false" aria-haspopup="true" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3576702%2F" role="button" target="_blank"><img alt="Share on Facebook" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626"/>
                             Facebook
                        </a></li><li class="twitter"><a aria-expanded="false" aria-haspopup="true" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3576702%2F&amp;text=Cannabinoid%20Hyperemesis%20Syndrome" role="button" target="_blank"><img alt="Share on Twitter" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627"/>
                             Twitter
                        </a></li><li class="gplus"><a aria-expanded="false" aria-haspopup="true" href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3576702%2F" role="button" target="_blank"><img alt="Share on Google Plus" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628"/>
                             Google+
                        </a></li></ul></div>
<div data-accid="PMC3576702" data-aid="3576702" data-aiid="3576702" data-domain="nihpa" data-domainid="319" data-iid="219807" data-md5="cf4e2d135ad77123ac4085fd13d697ec" data-pmid="22150623" id="ajax-portlets"><img align="absmiddle" alt="Loading..." src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/4018218/img/3631476"/> Loading portlets...</div>
<div class="col7">
</div>
</div>
</div>
<div class="col8">
</div>
<div class="col9">
</div>
<script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
<div id="body-link-poppers"></div>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<a class="help_desk" href="https://www.ncbi.nlm.nih.gov/" id="help-desk-link" target="_blank">Support Center</a>
<a class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-07-11T23:23:16-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8CD570D27F33F100000000052102AE&amp;ncbi_session=CE8CD570D27FD241_1313SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3576702%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" id="help-desk-link" target="_blank">Support Center</a>
</div>
<div class="footer" id="footer">
<div class="subfooter"> </div><script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/static/js/preloaderWidget.js" type="text/javascript"> </script>
<div class="offscreen_noflow" id="external-disclaimer">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>
<div class="contact_info" id="ncbifooter">
<div id="footer-contents-right">
<div id="nlm_thumb_logo">
<a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
</div>
<div id="nih_thumb_logo">
<a href="https://www.nih.gov" title="NIH">NIH</a>
</div>
<div id="hhs_thumb_logo">
<a href="https://www.hhs.gov" title="DHHS">DHHS</a>
</div>
<div id="usagov_thumb_logo">
<a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
</div>
</div>
<div id="footer-contents-left">
<p class="address vcard">
<span class="url">
<a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
<span class="adr">
<span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
<span class="region">MD</span>, <span class="postal-code">20894</span>
<span class="country-name">USA</span>
</span>
</p>
<a href="https://www.ncbi.nlm.nih.gov/home/about/policies.shtml">Policies and Guidelines</a> | <a href="https://www.ncbi.nlm.nih.gov/home/about/contact.shtml">Contact</a>
</div>
</div>
<script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1" type="text/javascript"> </script>
<script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/static/js/hfjs2.js" type="text/javascript"> </script>
</div>
</div>
</div>
</div>
</div>
<div aria-live="assertive" class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" style="display: none; top: 63.5938px; left: 651.688px; width: 670px; z-index: 1001;"><ul aria-activedescendant="term" class="ui-ncbiautocomplete-options" role="listbox"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" href="https://www.ncbi.nlm.nih.gov/#" style="display: block;">Turn off</a></div></div><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; top: -100px; left: -100px;">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
<span class="PAFAppResources"></span>
<noscript><img alt="statistics" src="https://www.ncbi.nlm.nih.gov/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3576702/&amp;ncbi_app=pmc"/></noscript>
<script snapshot="pmc" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" type="text/javascript"></script>
<div aria-describedby="epubDialog" aria-labelledby="ui-id-1" class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" role="dialog" style="display: none;" tabindex="-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span class="ui-dialog-title" id="ui-id-1">Making articles easier to read in PMC</span><button class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close" type="button"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div class="ui-dialog-content ui-widget-content" id="epubDialog" style="display: block;"> <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p> <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p> <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button class="ui-state-default ui-corner-all" id="cancelEpub">Cancel</button><button class="ui-state-default ui-corner-all" id="downloadEpub" style="float: left">Download article</button></div> </div></div></body></html>